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Abstract 
Unmitigated cellular stress is known to activate apoptosis, an active form of cell death 
requiring the coordinated expression of pro-death factors belonging to the Bcl-2 family of 
proteins. Once a critical threshold is reached, the pro-apoptotic effectors, BH3-only proteins, 
facilitate mitochondrial permeabilization and downstream caspase activation, culminating in 
cell death. A growing body of evidence suggests that key hallmarks of apoptosis are present 
in Alzheimer and Parkinson disease, and ischemic post-mortem brain tissue. Because of the 
delayed onset of the apoptotic process, recent efforts have been directed towards intervention 
strategies to reduce tissue loss and the concurrent symptomatic burden. Previous work from 
our group has demonstrated that the BH3-only protein, p53 Up-regulated Modulator of 
Apoptosis (PUMA), is critically important during neuronal apoptosis. In the current study, 
we investigated potential upstream regulators of PUMA in response to sustained neuronal 
stress conditions. Surprisingly, we found that ER-stress triggered PUMA expression 
independently of p53 in primary cortical cultures. Instead, we identified ATF4 and CHOP, 
key transcription factors of the integrated stress response, as crucial regulators of PUMA 
expression in response to ER dysfunction. Importantly, CHOP was found to directly 
transactivate the PUMA promoter. We also established that ATF4 played a significant role in 
the regulation of neuronal apoptosis triggered by sodium arsenite, an oxidative stressor 
capable of eliciting p53-independent cell death. ATF4 deletion strongly attenuated PUMA 
expression and caspase-3 activation induced by arsenite stress. Lastly, we subjected primary 
cortical cultures to continuous hypoxia, an important physiological stress involving ER 
dysfunction and reactive oxygen species generation, to identify critical apoptotic regulators. 
Reduced oxygen was found to be a potent stimulus driving PUMA expression however in the 
absence of p53 we did not observe any differences in PUMA levels or neuronal apoptosis. 
Rather, we found that chronic hypoxia induced ATF4, and ATF4 depletion significantly 
reduced PUMA mRNA and attenuated neuronal death. Because of the growing economic and 
familial impact of chronic neurodegenerative conditions and ischemic incidents, identifying 
viable therapeutic targets is critical to preserving functional integrity. We suggest that 
inhibiting ATF4 may be a valid candidate to consider. 
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Chapter 1  
1 Introduction 
1.1 The current impact of acute neuronal injury and chronic 
neurodegenerative diseases 
The lasting impact of acute neuronal injury such as stroke and chronic neurodegenerative 
diseases is considerable and may persist long after the initial diagnosis. For instance, the 
cost of care incurs a significant financial and psychological burden on caregivers. Recent 
estimates have shown that stroke costs the Canadian economy upwards of $3 billion per 
year. Additionally, if left unchanged the cost of Alzheimer disease is projected to exceed 
$240 billion in 2040. Moreover, caregivers themselves are susceptible to developing 
psychological illnesses, most commonly depression. Further complicating the matter is 
the growing population of seniors, who are particularly vulnerable to developing 
cognitive illnesses. Over 80% of Parkinson disease patients are over the age of 65 and 
treatments directed at managing its symptoms can reach a monthly cost of $1,000. Taken 
together, the innovation of new treatments that can improve the quality of life for the 
patient is a primary initiative. This is particularly important for Amyotrophic Lateral 
Sclerosis, who on average have a limited life expectancy between 2 to 5 years, following 
diagnosis (Als.ca; Alzheimer.ca; heartandstroke.ca; Parkinson.ca). 
 
The goal of this thesis is to nominate candidate genes that might play a key role in 
mediating neuronal death after acute neuronal injury and during chronic 
neurodegenerative illnesses, thus becoming potential therapeutic targets. 
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1.2 Pathways of Cell Death 
1.2.1 Apoptosis 
Apoptosis is an active and regulated form of programmed cell death requiring the 
induction and interaction of various proteins in order to maintain cellular homeostasis. 
This process plays a key role in neurodevelopment during synaptogenesis as well as in 
the removal of damaged, cancerous or senescent cells. Key hallmarks of apoptosis 
include DNA fragmentation, chromatin condensation, cleavage of cellular components, 
and the appearance of apoptotic bodies (Buss et al., 2006). The targeted disposal of 
redundant cells is resolved via phagocytosis of apoptotic debris, thus preventing an 
inflammatory response (Savill et al., 1989). Despite the necessity for homeostatic 
apoptosis, a growing body of evidence suggests that apoptotic cell death plays a critical 
role in the pathology associated with chronic neurodegenerative conditions such as AD 
(Overmyer et al., 2000), PD (Hartmann et al., 2000; Viswanath et al., 2001), traumatic 
brain injury (TBI) (Smith et al., 2000), and acute neuronal injury (Rami et al., 2003). 
Moreover, similar findings have been demonstrated using in vitro and animal models of 
ALS (Kieran et al., 2007), AD (Xie et al., 2013), brain ischemia (Plesnila et al., 2001; 
Gibson et al., 2001), and PD (Ryu et al., 2002; Perier et al., 2007).  
1.2.2 Necrosis 
In contrast to the ordered and energy-dependent process of apoptosis, necrotic cell death 
is characterized as a passive, rapid and deregulated form of cellular injury that is 
consistently harmful. The loss of membrane integrity facilitates ion fluxes and the escape 
of cellular contents into the extracellular environment, triggering widespread 
inflammation and immune cell infiltration (Sauter et al., 2000; Fink and Cookson, 2005). 
Morphologically, necrosis also displays non-specific DNA cleavage due to the absence of 
coordinated enzymatic nuclear fragmentation, a notable feature of apoptotic cell death 
(Fink and Cookson, 2005). 
Due to the accelerated pace of necrosis, the goal of this thesis is to elaborate the signaling 
components regulating the staggered and deliberate process of apoptotic cell death, an 
execution program that is susceptible to therapeutic intervention. 
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1.3 The BCL-2 Family 
Apoptosis is regulated by the B cell lymphoma-2 (Bcl-2) family of proteins, which is 
comprised of two classes: pro- and anti-apoptotic effectors. Bcl-2 members are 
distinguished by the varying presence of 4 unique Bcl-2 homology (BH) domains that 
permit the binding of death-inducing and survival molecules via their BH3 domain. In 
healthy cells, BH3-only pro-apoptotic proteins, BID and BAD, require post-translational 
modifications in order to gain lethality, while Puma, Noxa and Bim are regulated 
primarily via transcriptional mechanisms. Conversely, anti-apoptotic proteins, Bcl-2, Bcl-
xL, MCL-1, are abundantly expressed in unstressed cells. Pro-survival proteins function 
to sequester the pro-apoptotic, BAX, from interacting with other BAX molecules. In 
response to apoptotic stimuli, stressed cells induce BH3-only proteins to activate BAX 
(Figure 1.1). The manner by which this is achieved is controversial although, two 
competing theories exist to further this notion. In the direct activation model, BH3-only 
ligands are subdivided into two groups: sensitizers or activators. Sensitizers, like BAD 
and NOXA, engage pro-survival members to prevent their binding to Activators, PUMA, 
BIM or BID, which can directly associate with BAX. The indirect model suggests that 
BH3-only molecules do not interact with BAX. Instead, each BH3-only protein can bind 
to a varying spectrum of anti-apoptotic proteins and induce the dissociation of BAX, 
facilitating its oligomerization at the outer mitochondrial membrane (OMM) (Figure 1.2) 
(Kim et al., 2006; Willis et al., 2007; Youle and Strasser, 2008). 
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Figure 1.1. The BCL-2 family of proteins.  
Apoptosis is regulated by the interplay of pro- and anti-apoptotic proteins. Anti-apoptotic 
members are comprised of 4 BH domains and a unique C-terminal transmembrane 
domain (TM), which facilitates organelle docking. Pro-apoptotic variants consist of BH3-
only proteins such as PUMA, BIM and NOXA, which harbor a single BH domain. 
Additionally, BAX and BAK are classified as pro-apoptotic multidomain members that 
express BH domains 1-3 and a TM (Youle and Strasser, 2008).  
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Figure 1.2. Proposed models of BAX activation.  
In the direct activation model, PUMA, BIM and BID are ascribed as activators, which 
implies their ability to engage and activate BAX directly or through the uncoupling of 
BAX bound to an anti-apoptotic member. In contrast to activators, NOXA and BAD 
function as sensitizers by dissociating BAX and anti-apoptotic proteins thereby 
facilitating BAX activation. In the indirect activation model, PUMA can promiscuously 
disengage any pro-survival variant from its quiescent complex with BAX to trigger 
apoptosis. As a selective BH3-only protein, BAD is limited to bind specific anti-apoptotic 
ligands to enable BAX activation (Adams and Cory, 2007). 
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1.3.1 Pathways of Apoptosis 
The extrinsic pathway of apoptosis, also known as the death-receptor pathway, is a 
critical signaling axis utilized by immune cells, which is modulated by extracellular 
signaling molecules that bind to cell surface death receptors.  
The intrinsic pathway of apoptosis or the mitochondrial pathway, responds to 
intracellular perturbations such as, disruptions in Ca
2+
 flux, oxidative dysfunction or 
DNA damage. These apoptotic stimuli shift the balance of Bcl-2 expression favoring the 
augmentation of BH3-only pro-death ligands. BH3-only proteins can participate in either 
the direct or indirect activation of BAX. The key function of BAX is to oligomerize at the 
OMM, forming a pore that connects the intermembrane space to the cytoplasm, 
facilitating mitochondrial membrane permeabilization and the subsequent release of 
cytochrome c. In the cytosol, cytochrome c associates with pro-caspase-9, apoptotic 
protease-activating factor-1 (APAF-1) and dATP, in a complex known as the 
apoptosome. In the final stage of the apoptotic process, the apoptosome activates a 
specific family of cysteine-aspartate proteases (caspases) that sequentially deconstruct the 
cellular architecture (Adams and Cory, 2007; Green and Kroemer, 2004). The resulting 
cellular debris is phagocytized by circulating immune cells, which prevents widespread 
inflammation (Figure 1.3) (Fink and Cookson, 2005).  
Caspases are classified into 2 categories: initiator (e.g. caspases-2, -8, -9, -10) and 
executioner (e.g. caspases-3, -6, -7), and are largely expressed as inert zymogens that 
require proteolysis to become fully functional. Although the extrinsic and intrinsic 
pathways are distinctly activated, both signaling cascades converge upon caspase-3. 
Moreover, both pathways have the potential to intersect following the activation of 
caspase-8, of the extrinsic pathway, which can cleave the BH3-only protein, BID, to its 
active form, truncated BID (tBID). The conversion of BID enables the intrinsic pathway, 
facilitating BAX activation and homodimerization at the OMM (Strasser et al., 2000). 
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Figure 1.3. The intrinsic pathway of apoptosis.  
Upon a fatal stress signal, BAX becomes activated and oligomerization takes place at the 
OMM. Embedded BAX oligomers form a pore connecting the cytoplasm with the 
intermembrane space, which allows cytochrome c to escape into the intracellular 
environment. Cytochrome c then pairs with pro-caspase-9, APAF-1 and dATP, forming 
the apoptosome, a complex necessary to convert the zymogen, pro-caspase-3, to its active 
cleaved form. Caspase-3 serves as a key executioner protease that disassembles cellular 
components (Youle and Strasser, 2008). 
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1.4 Cell Stress Pathways 
1.4.1 Oxidative Stress 
Oxidative stress is defined as the imbalance of reactive oxygen species (ROS) generation 
relative to the detoxifying actions of intrinsic antioxidant enzymes. ROS can cause 
damage to cellular lipids, proteins and DNA, and this is sufficient to induce apoptosis. 
The mitochondrion is central to the generation of ROS due to the process of oxidative 
phosphorylation that yields the vital energy currency of the cell, ATP, and the detrimental 
byproduct, superoxide anion (O2
-
). Oxidative phosphorylation occurs by the sequential 
cycling of electrons over mitochondrial complexes (I-IV) of the electron transport system 
(ETS), embedded in the inner mitochondrial membrane, culminating in the reduction of 
O2 to water, at complex IV, and the creation of ATP at complex V. Over the course of 
electron transfer, leakage may occur at complexes I and III enabling electrons to interact 
with O2, generating of O2
-
, a volatile free radical capable of damaging other molecules. 
Intrinsic antioxidant defenses such as superoxide dismutase (SOD) can convert O2
-
 to 
hydrogen peroxide (H2O2), which can be detoxified by catalase, producing water. In 
order to bolster further protection, cells also contain non-enzymatic ROS scavengers like 
vitamin E, vitamin C and glutathione (GSH) (Figure 1.4) (Uttara et al., 2009; D’Autreaux 
and Toledano, 2007; Perier and Vila, 2012).  
ROS can also be generated via enzymatic sources, such as NADPH oxidases (NOX), 
xanthine oxidase (XO) and neuronal nitric oxide synthase (nNOS), which play key roles 
in modulating tissue damage following seizures and ischemic insults (Sattler et al., 1999; 
Luo et al., 2014; Bagetta et al., 2002; Suzuki et al., 2012; Kovac et al., 2014). Although 
ROS are typically associated with pathological functions, endogenous production of the 
reactive nitrogen species (RNS) free radical, nitric oxide (NO), can perform important 
physiological functions such as vasodilation (Quillon et al., 2015).  
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Figure 1.4. The mitochondrial electron transport system.  
The mitochondrion relies on the efficient shuttling of electrons through the ETS in order 
to produce ATP via oxidative phosphorylation. Initially, reduced nicotinamide adenine 
dinucleotide (NADH) is oxidized to NAD+, in the mitochondrial matrix. The liberated 
electron (e
-
) is then transferred through mitochondrial complexes I-IV, which are 
dispersed throughout the inner mitochondrial membrane. Protons (H
+
) found in the 
matrix are also redistributed to the intermembrane space at complexes I, III and IV. As a 
consequence of e
-
 transport, reactive oxygen species (ROS) formation can occur at 
complexes I and III. The final step of the ETS involves passing e
-
 through complex IV 
into the matrix where O2 is reduced to form water (H2O). At complex V or ATP synthase, 
the accumulated H
+
 within the intermembrane space form a significant concentration 
gradient with the matrix, and diffuse through complex V into the matrix. The kinetic 
energy generated through the excessive H
+
 transfer powers the enzymatic complex V to 
generate ATP (Perier and Vila, 2012). 
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1.4.2 The Endoplasmic Reticulum (ER) stress response 
Under normal conditions, the ER directs lipid biosynthesis, Ca
2+
 homeostasis and the 
modification, transport, and development of nascent proteins. The ER also modulates the 
degradation of misfolded proteins via a regulated process known as Endoplasmic 
Reticulum-Associated Degradation (ERAD), which involves cytoplasmic export and 
disposal by the ubiquitin-proteasome system. During periods of stress, where normal ER 
function is impaired and improperly folded proteins accumulate beyond the homeostatic 
threshold, an ER-stress response is triggered. In order to restore balance, the ER 
implements a specific signaling cascade, the unfolded protein response (UPR), to arrest 
further protein synthesis thereby reducing the protein load within the ER lumen. UPR 
signaling also results in the up-regulation of genes involved with the trafficking and 
degradation of misfolded aggregates (Hetz, 2012).  
1.4.2.1 The Unfolded Protein Response (UPR) 
The initial phase of the UPR involves the activation of 3 transmembrane sensors: 
Activating Transcription Factor-6 (ATF6), PKR-like ER kinase (PERK), and Inositol 
Regulating Kinase 1 (IRE1). Under quiescent conditions, these sensors are held inactive 
via bound molecules of the ER chaperone, Binding Immunoglobulin Protein (BiP). In 
response to the increasing presence of misfolded proteins, BiP disengages the luminal 
border of the ER sensors and binds unfolded aggregates, targeting them for ERAD (Hetz, 
2012). 
ATF6 is a Basic-region leucine zipper (bZIP) member of the ATF/CRE family of 
transcription factors and is expressed as 2 distinct isoforms, ATF6α (90kDa) and ATF6β 
(110kDa) that exist as ER membrane-bound proteins (Yoshida et al., 2001). In response 
to ER-stress, ATF6α and ATF6β are released from inhibition via BiP, translocate to the 
Golgi Apparatus where they are processed by Site 1 and Site 2 Proteases (S1P/S2P), 
yielding 50-60 kDa transcriptionally active fragments, ATF6αf/ATF6βf. Although both 
ATF6αf and ATF6βf can transactivate the same promoters consisting of ER-Stress 
Elements (ERSE) or Unfolded Protein Response Elements (UPRE), it is believed that 
ATF6α drives transcription whereas ATF6β represses ER-stress-related gene expression 
11 
 
(Thuerauf et al., 2004). Additionally, it was demonstrated that the cleavage of ATF6α 
appears prior to the accumulation of ATF6βf, supporting the notion of an endogenous 
deactivating signal (Haze et al., 2001). The role of ATF6α is primarily to facilitate ERAD 
via ER chaperone expression (Haze et al., 1999; Ye et al., 2000).  
The induction of the ubiquitous isoform of IRE1, IRE1α requires homodimerization and 
autophosphorylation (Bertolotti et al., 2000). Upon activation, IRE1α can promote the 
expression of chaperones to facilitate ERAD, and has the potential to modulate apoptosis. 
Following the dissociation of BiP, the cytoplasmic domain of IRE1α employs its 
endoribonuclease activity to cleave a 26-nucleotide sequence from an unspliced X-box 
binding protein-1 (Xbp1)  mRNA, yielding the bZIP transcription factor, XBP1s, which 
regulates the expression of ER chaperones independently or cooperatively with its 
potential binding partner, ATF6αf (Lee et al., 2003). XBP1 is thought to play a key role 
during brain development as evidenced in neurons lacking XBP1, which displayed poor 
neurite outgrowth and reduced axonal branching (Hayashi et al., 2007). IRE1α can also 
mediate apoptosis via the activation of Apoptosis Signaling Kinase-1 (ASK1), which in 
turn induces Jun N-terminal Kinase (JNK) (Tobiume et al., 2001). JNK has been linked 
with BIM activation, and the down-regulation of Bcl-2 (Putcha et al., 2003; Yamamoto et 
al., 1999). 
The final ER-stress sensor, PERK is activated by mounting levels of protein aggregates in 
the ER compartment and the release of inhibition by BiP (Bertolotti et al., 2000). Once 
BiP has dissociated from the luminal domain of PERK to engage misfolded proteins, 
PERK dimerizes and undergoes autophosphorylation, targeting eukaryotic Initiation 
Factor-2α (eIF2α) for phosphorylation at Serine 51 (P-eIF2α). This results in a global 
attenuation of protein translation to ease the load of unfolded proteins in the ER. The 
process of eIF2α phosphorylation in response to stressful stimuli is known as the 
integrated stress response (ISR). Other cellular stresses capable of inducing the ISR are 
mediated by specific eIF2α kinases such as, Protein Kinase RNA-activated (PKR) in 
response to dsRNA, General Control Nonderepressible 2 (GCN2) activated by amino 
acid deprivation, and Heme-Regulated Inhibitor Kinase (HRI) triggered by heme-
deficiency (Baird and Wek, 2012). Although protein synthesis is reduced under these 
12 
 
conditions, a specific subset of mRNAs are preferentially translated, such as Activating 
Transcription Factor-4 (ATF4), C/EBP Homologous Protein (CHOP), and Growth Arrest 
and DNA damage-inducible 34 (GADD34) (Figure 1.5). This specialized mechanism of 
translation is thought to involve the presence of inhibitory uORFs that are bypassed 
during translational arrest, allowing for the efficient ribosomal scanning of the coding 
region (Vattem and Wek, 2004; Lee et al., 2009; Palam et al., 2011).  
ATF4 is a critical downstream effector of the ISR regulating a variety of responses 
including antioxidant gene expression, amino acid synthesizing enzymes and pro-
apoptotic machinery (Ameri and Harris, 2008; Hetz and Mollereau, 2014). CHOP is an 
ATF4-target gene known to facilitate the apoptotic process via the down-regulation of 
Bcl-2 (McCullough et al., 2001). GADD34 encodes a regulatory subunit of the Protein 
Phosphatase-1 (PP1) -containing complex that is essential in modulating the 
phosphorylation status of eIF2α, and thus serves as a negative regulator of translational 
arrest (Novoa et al., 2003). 
The failure to resolve ER-stress due to prolonged UPR activation, leads to an adaptive 
switch from homeostatic restoration to an apoptotic profile, for reasons that remain 
unclear, but may be due to the accumulation of ATF4 and CHOP, which can induce pro-
apoptotic mRNAs (Rutkowski et al., 2006; Hetz and Mollereau, 2014). For example, 
CHOP has been shown to up-regulate PUMA and BIM expression while suppressing Bcl-
2 mRNA in response to ER dysfunction (McCullough et al., 2001; Cazanave et al., 2010; 
Puthalakath et al., 2007). 
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Figure 1.5. The Endoplasmic Reticulum stress response.  
The accumulation of misfolded proteins within the ER lumen induces the ER chaperone, 
BiP, to disengage the luminal domains of ER-membrane bound sensors: PERK, IRE1α 
and ATF6α, and sequester the newly formed aggregates. Upon dissociation from BiP, all 
the ER sensors are activated. PERK dimerizes and is autophosphorylated, which leads to 
the phosphorylation of eIF2α and a reduction in protein synthesis. Under this condition, 
Atf4 mRNA is uniquely translated and generates a potent transcriptional regulator. IRE1α 
activation also requires dimerization and autophosphorylation, which results in the 
processing of Xbp1 mRNA into a truncated and transcriptionally active species, XBP1s. 
Finally, ATF6α localizes to the Golgi Apparatus where it undergoes enzymatic cleavage 
via Site 1 and Site 2 proteases (S1P/S2P), generating the transcription factor, ATF6αf 
(Hetz, 2012). 
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1.4.2.2 The ATF/CREB Family of Transcription Factors 
ATF4 is a critical bZIP transcriptional regulator of the ISR that directs the expression of 
amino acid synthesizing enzymes, antioxidant and chaperone responses, and pro-
apoptotic genes (Baird and Wek, 2012). Members of the ATF/CREB family are 
composed of a DNA-binding basic region and a promiscuous leucine zipper dimerization 
domain that enables several combinations of homo- and hetero-dimers to drive 
transcription (Ameri and Harris, 2008). The composition and function of the dimers is 
strongly dependent upon the nature of the stress and will dictate gene repression or 
activation (Lassot et al., 2005; Soda et al., 2013). For example, ATF4 can interact with 
Activator Protein-1 (AP-1) and other C/EBP family members that recognize and bind to 
the CRE consensus site (TGACGTCA). Levels of ATF4 have been demonstrated to 
accumulate in response to a wide array of cellular stresses, such as ER and oxidative 
dysfunction, hypoxia, Aβ toxicity and nutrient deprivation (Armstrong et al., 2010; Ryu 
et al., 2002; Halterman et al., 2008; Baleriola et al., 2014; Lange et al., 2008). Although 
little is known regarding ATF4 transcription, Atf4 mRNA is thought to be induced by the 
transcription factors, NRF2 and CLOCK, whereas the liver-enriched inhibitory protein 
(LIP) isoform of CCAAT-enhancer-binding protein-β (C/EBPβ) has been shown to 
antagonize its expression (Afonyushkin et al., 2010; Miyamoto et al., 2011; Igarashi et 
al., 2007; Dey et al., 2012). In order for the Atf4 message to be efficiently translated, 
eIF2α must be phosphorylated at serine 51, a modification indicative of translational 
suppression. Interestingly, Atf4 mRNA exhibits two upstream open reading frames 
(uORF) 1 and 2 that pose as positive and negative-acting elements, respectively. Stimuli 
that induce the ISR will promote P-eIF2α and delay the reacquisition of the translational 
complex as a manner to bypass uORF 2, leading to the enhanced translation of the Atf4 
coding region (Vattem and Wek, 2004). 
ATF4 protein stability is thought to be modulated by several mechanisms. Firstly, by the 
ATF4-inducible GADD34, a negative regulator of P-eIF2α, a condition associated with 
optimal ATF4 translation and the resumption of protein synthesis (Novoa et al., 2003). 
Second, ATF4 has been shown to be phosphorylated on serine residues by the protein 
kinases, CK1 and CK2, spanning amino acids 215-219, a region thought to facilitate the 
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interaction with the F box protein, β-TrCP leading to the ubiquitination and degradation 
of ATF4 (Frank et al., 2010; Ampofo et al., 2013). Finally, ATF4 stability was shown to 
be heavily dependent upon the activity of the oxygen sensor, prolyl-4-hydroxylase 3 
(PHD3), and the hydroxylation of prolyl residues within the oxygen degradation domain 
of ATF4. During periods of normoxia, PHD3 function is robust and suppresses ATF4 
accumulation. Conversely, hypoxia impairs PHD3 activity thus allowing the 
enhancement of ATF4. Whether PHD3-mediated hydroxylation of ATF4 involves β-
TrCP-induced ubiquitination, and subsequent degradation, remains unclear (Köditz et al., 
2007).  
1.4.3 ER-Stress and Oxidative Stress are linked 
Unmitigated ER-stress leads to the resumption of protein translation and the 
accumulation of pro-death modulators of the UPR such as, ATF4 and CHOP. The 
termination signal that recapitulates translation is carried out by the joint action of 
PP1/GADD34 complex leading to the dephosphorylation of eIF2α (Hetz, 2012). Both 
ATF4 and CHOP play a pivotal role in the resumption of translation via the regulation of 
GADD34 expression (Han et al., 2013). Because the rate of protein synthesis is 
increased, there is a corollary incline in the formation of disulfide bonds within the ER 
lumen. This is achieved by the cooperative functioning of the critical foldases, ER 
oxidoreductin-1α (ERO1α) and Protein Disulfide Isomerase (PDI), which are induced as 
a result of prolonged UPR stimulation. In the ER lumen, ERO1α oxidizes PDI, which 
then transfers its electrons to client thiol proteins enabling disulfide bond formation. As a 
by-product of continuous ERO1α-PDI functioning, ERO1α can eventually reduce O2 to 
H2O2, thereby generating ROS indirectly through enhanced translation. One of the 
endogenous coping mechanisms relies on the scavenger GSH, which is converted to 
oxidized GSH (GSSG) throughout the folding process. Even though GSH is abundant in 
multiple cellular compartments, the strongly oxidizing environment within the ER can act 
as a sink to GSH defenses. The depletion of GSH pools to GSSG impairs ROS 
scavenging within the cell, in particular, at the mitochondrion during oxidative 
phosphorylation where electrons can escape the ETS to generate ROS (Tu and Weissman 
et al., 2004). It was recently demonstrated that targeted knockdown of ERO1α enhanced 
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survival in response to either ATF4 or CHOP overexpression (Han et al., 2013). 
Moreover, cell death triggered by prolonged ER-stress requires mitochondrial 
involvement, as demonstrated in ρ0 cells, which lack mitochondria (Haynes et al., 2004). 
This finding strongly implicates mitochondrial ROS generation as a key contributor to 
apoptosis triggered by extended ER dysfunction. 
1.4.4 DNA damage 
1.4.4.1 P53 
The tumor suppressor, p53, is a critical transcriptional activator capable of mounting cell 
death responses, attenuating cell division and inducing DNA repair. Collectively, these 
functions have labeled p53 as, “the guardian of the genome”, and are beneficial against 
the cycling of damaged cells harboring DNA mutations with the potential of becoming 
neoplastic. Indeed, p53 is mutated in 50% of all human cancers largely within its DNA-
binding domain, which impairs its transcriptional function. P53 is maintained at low 
levels throughout the body by the protein MDM2, which facilitates its ubiquitination and 
degradation, until it is stabilized by stressful stimuli, like DNA damage. Other stresses 
capable of accumulating p53 include oxidative stress, severe hypoxia and 
chemotherapeutic agents (Perier et al., 2007; Hammond et al., 2002; Haupt et al., 2003). 
Under conditions where too much damage has accrued, p53 can induce several pro-death 
genes linked to both the extrinsic and intrinsic pathways of apoptosis. P53 can up-
regulate key death-receptor associated genes, Fas and DR5, that play an essential role 
during the initial phase of the extrinsic pathway. The intrinsic pathway can be facilitated 
by p53-dependent increases in BAX, NOXA, PUMA and APAF-1 (Haupt et al., 2003). 
The adaptive switch from a restorative signaling axis converting to an apoptotic program 
is speculated to involve shifting levels between the cell cycle inhibitor, p21 and rising 
amounts of PUMA (Yu et al., 2003).  
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1.5 Chronic Neurodegenerative Disease 
Alzheimer Disease (AD) is a chronic neurodegenerative condition resulting in the gradual 
decline of cognitive and executive functions. A hallmark of the disorder is the 
accumulation of toxic plaques consisting of amyloid-beta (Aβ) deposits and 
neurofibrillary tangles composed of hyperphosphorylated tau. Aβ is produced by the 
sequential cleavage of amyloid precursor protein (APP) by β- and γ-secretase enzymes. 
The most common cleavage variant of APP is a 40-amino acid species however it is the 
42-amino acid product that is a key initiator of Aβ aggregation and neuronal cell death 
(Perrin et al., 2009; Palop and Mucke, 2010; Nakagawa et al., 2000; Biswas et al., 2007; 
Feng et al., 2014). It was recently demonstrated that amyloid plaques contribute to the 
induction of neuronal apoptosis in vivo (Xie et al., 2013). 
Parkinson Disease (PD) is the second most common neurodegenerative condition after 
AD, and involves a gradual loss of neuronal tissue in the midbrain. Symptoms of PD 
include deficits in motor control due to the progressive ablation of dopaminergic neurons 
of the substantia nigra pars compacta (SNpc) located in the mesencephalon. Other 
distinguishing pathological features include the presence of intraneuronal inclusions 
comprised of aggregated alpha-synuclein (αS), known as Lewy bodies, and mitochondrial 
deficits. The exact mechanism leading to dopaminergic cell death is still unclear but may 
involve oxidative dysfunction originating from a breakdown in the shuttling of electrons 
within mitochondria. Indeed it has been shown that mitochondrial complex I deficiency is 
pronounced in autopsied PD brains (Mizuno et al., 1989). Moreover it is known that 
exogenous exposure to 1-methyl-4-phenyl-1, 2, 3, 6-tetra-hydropyridine (MPTP), which 
is converted intrinsically to 1-methyl-4-phenylperidinium (MPP+), is a potent inhibitor of 
complex I function and induces Parkinsonism in humans and rodents. 
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Amyotrophic Lateral Sclerosis (ALS) or Lou Gehrig’s disease is a progressive 
neurodegenerative disorder specifically affecting motor neuron survival resulting in 
profound skeletal muscle disruptions ultimately becoming fatal. Although most cases of 
ALS are sporadic in origin, a smaller portion is inherited arising from mutations in the 
superoxide dismutase-1 (SOD1) gene, an important component of the body’s antioxidant 
defense system. It is suspected that impaired SOD1 function facilitates oxidative stress, 
which if improperly buffered can trigger apoptosis (Kieran et al., 2007; An et al., 2014). 
 
1.5.1 The BCL-2 Family and Neuronal Cell Death 
A substantial body of work has shown that the Bcl-2 family plays an essential role in the 
pathogenesis associated with acute neuronal injury (ischemia, epilepsy, TBI) and chronic 
neurodegenerative conditions (PD, AD, ALS). As such, many groups have employed the 
use of gene-specific knockout mice to evaluate their influence in this context. 
1.5.2 The BCL-2 Family and Chronic Neurodegenerative Disease 
Within the context of chronic neurodegeneration, the pro-apoptotic Bcl-2 member, BAX, 
was found to be significantly enriched after Aβ treatment in vitro, and in autopsied AD 
brain tissue, relative to age-matched controls (Paradis et al., 1996; Su et al., 1997; Lu et 
al., 2005). Similar findings were demonstrated in human PD nigral neurons and 
neurotoxin-induced experimental PD in the mouse midbrain, where BAX expression was 
robustly accumulated (Tatton, 2000; Vila et al., 2001). Because BAX is an essential 
gateway of the apoptotic process, the targeted disruption of BAX was pursued to 
establish a critical link between neuronal death and chronic neurodegenerative pathology. 
This notion was supported by recent work indicating that BAX-depleted neurons were 
significantly protected against Aβ toxicity, a modulator of caspase-dependent neuronal 
apoptosis in vivo (Kudo et al., 2012; Xie et al., 2013). Additionally, the neurotoxic effects 
of drug-induced PD were completely mitigated in the SNpc of BAX
-/- 
mice, in contrast to 
wild type controls (Vila et al., 2001). In an animal model of ALS, BAX
-/-
-SOD1
G93A
 mice 
showed enhanced motor neuron survival and lifespan compared with SOD1
G93A
 
littermates (Gould et al., 2006; Reyes et al., 2010). Interestingly, BAX oligomerization 
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was profoundly increased in human post-mortem ALS brains, relative to control cases 
(Martin, 1999).  
Knockdown of the BH3-only protein, BIM reduced neuronal death triggered by Aβ 
toxicity in vitro, while autopsied AD brain tissue has identified BIM as a potential 
contributor to neuronal loss in vivo (Biswas et al., 2007). BIM was also noted as a key 
participant in the modulation of dopaminergic cell loss in an animal model of PD, and 
disease onset and survivability in ALS model mice (Perier et al., 2007; Hetz et al., 2007). 
Similarly, double mutant SOD1
G93A
-PUMA
-/-
 mice showed delayed motor neuron death, 
relative to SOD1
G93A
-PUMA
+/+
, in an ALS animal model of disease (Kieran et al., 2007). 
Moreover, PUMA has been implicated as a key mediator of MPP+ and Aβ-induced 
neuronal apoptosis, and was strongly up-regulated within the brains of AD model mice, 
compared with littermate controls (Steckley et al., 2007; Akhter et al., 2014; Feng et al., 
2014). Taken together, there is sufficient evidence to suggest the involvement of the 
intrinsic pathway in the pathogenesis of several progressive neurodegenerative 
conditions. 
1.5.2.1 PUMA and Neuronal Cell Death 
PUMA was originally described as a p53-target gene in response to DNA damaging 
agents, but could also be induced independently of p53 by serum-withdrawal and 
dexamethasone treatment, in non-neuronal systems (Nakano and Vousden, 2001; Yu et 
al., 2001; Han et al., 2001). The discovery of p53-independent apoptotic gene expression 
was critical for the design of chemotherapeutic agents that could circumvent p53 
mutations in cancer, which impair its transcriptional function and facilitate cellular 
transformation. Although some of the difficulty surrounding the treatment of cancer 
involves a lack of p53-mediated apoptosis, it is rather the heightened response of p53 that 
is problematic in acute neuronal injury and in chronic neurodegenerative conditions. For 
instance, p53-null mice show reduced infarct sizes compared with wild type, in an in vivo 
stroke model (Crumrine et al., 1994). p53 has also been identified in post-mortem human 
AD, PD and ALS nervous tissue (de la Monte et al., 1998; Kitamura et al., 1997). 
Consistent with this, the Parkinsonian mimetics, MPP+ and 6-OHDA, have been shown 
to induce PUMA in a p53-dependent manner (Bernstein et al., 2011; Bernstein and 
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O’Malley, 2013). Spinal tissue from ALS transgenic mice expressing SOD1G93A showed 
a progressive increase in Puma mRNA, relative to wild type. Moreover, PUMA
-/-
- 
SOD1
G93A
 mice displayed significantly longer motor neuron survival (Kieran et al., 
2007). Also, it was recently demonstrated that Aβ treatment in vitro can trigger PUMA 
expression, which is partially dependent upon p53 (Akhter et al., 2014; Feng et al., 2014). 
This notion was extended in neuronal cells when it was later demonstrated that PUMA 
could be induced in p53-deficient neurons treated with ER- and oxidative stressors 
(Fricker et al., 2010; Wong et al., 2005). Some proposed p53-independent transcriptional 
activators of PUMA include, p73, FOXO3a, ATF4, CHOP, AP-1 and E2F1 (Fricker et 
al., 2010; Melino et al., 2004; Akhter et al., 2014; Feng et al., 2014; Qing et al., 2012; 
Cazanave et al., 2010; Hershko and Ginsberg, 2004). 
 
1.5.3 Oxidative Stress and Chronic Neurodegenerative Disease 
Oxidative dysfunction was recently implicated as a probable mechanism instigating 
caspase-dependent neuronal loss in vivo, in an animal model of AD. Healthy neurons 
within close proximity to amyloid plaques were found to undergo oxidative stress and 
subsequent neuronal death (Xie et al., 2013). Although AD, PD and ALS are unique with 
respect to their distinctly affected neuronal populations, these conditions share a similar 
trait throughout their pathologies in that they are proteopathies. Specifically, Aβ 
production can be furthered by ROS leading to enhanced plaque deposition, αS can be 
modified into a more aggressively aggregating species and nitration of SOD1 impairs its 
antioxidant capacity, indirectly facilitating toxic ROS modifications to other proteins 
(Giasson et al., 2000; Aoyama et al., 2000; Liu et al., 2007; Leuner et al., 2012). 
Although oxidative stress is thought to play a significant role in the pathogenesis of 
several neurodegenerative diseases, little is known regarding the signaling events 
regulating neuronal death. In order to elucidate those mechanisms, multiple in vitro 
models have been employed using synthetic inducers of oxidative dysfunction capable of 
replicating the phenotypes observed in vivo. For example, PD is characterized by the 
gradual depletion of dopaminergic neurons within the substantia nigra pars compacta 
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(SNpc), a region of the midbrain responsible for motor control tuning. One of the in vitro 
modeling systems involves the use of animal-sourced mesencephalic neurons treated with 
the toxic metabolite of MPTP, MPP+, a synthetic inducer of oxidative stress capable of 
selectively destroying the SNpc. Similar to the observed deficit in human PD post-mortem 
brain tissue involving reduced amounts of mitochondrial complex I, MPP+ functions to 
specifically inhibit complex I and impair electron flow through the ETS (Mizuno et al., 
1989). Because the mitochondrion is a primary hub for the generation of ROS, 
perturbations of the ETS can overwhelm intrinsic antioxidants, leading to oxidative stress 
and apoptosis. It has been suggested that oxidative stress-induced neuronal apoptosis 
triggered by MPP+ requires de novo gene expression and this likely involves key 
contributions from the Bcl-2 family (Choi et al., 1999; Steckley et al., 2007). Although 
oxidative dysfunction can induce the expression of multiple BH3-only genes, only 
PUMA was critical for neuronal apoptosis whereas BIM and NOXA were dispensable 
(Steckley et al., 2007). One of the key transcriptional regulators of PUMA is the tumor 
suppressor, p53, which has been shown to mediate PUMA expression in response to 
specific oxidative stressors and not with others, indicating the existence of p53-
independent pathways (Nakano and Vousden, 2001; Yu et al., 2001; Steckley et al., 2007; 
Fricker et al., 2010). One of those agents is the environmental toxicant, sodium arsenite 
(arsenite), which has been shown to induce a potent pro-oxidant function in part via 
protein oxidation and lipid peroxidation (Samuel et al., 2005; Lin et al., 2007). Moreover, 
arsenite has been widely used experimentally in a variety of in vitro  and in vivo models 
of neurotoxicity (Fricker et al., 2010; Mengesdorf et al., 2002; Wong et al., 2005; 
Namgung and Xia, 2000; Lin et al., 2007; Fan et al., 2010). Furthermore, arsenite has 
been shown to mediate apoptosis in a PUMA-dependent but p53-independent manner, 
suggesting that other factors compensate for the absence of p53, in this context (Fricker 
et al., 2010). 
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1.5.4 ER-stress and Chronic Neurodegenerative Disease 
Protein aggregation is a hallmark feature in a variety of neurodegenerative conditions 
such as, Aβ peptides in AD, α-synuclein (αS) in PD, and mutant SOD-1 in ALS (Taylor 
et al., 2002; Soto, 2003; Kikuchi et al., 2006). Similarly, autopsied human AD brains 
showed a pronounced up-regulation of ER-stress-related factors, compared with control 
brains (Yoon et al., 2012; O’Connor et al., 2008; Baleriola et al., 2014). Baleriola and 
others (2014) recently demonstrated that targeted knockdown of ATF4 was able to 
significantly reduce Aβ-induced neurotoxicity in vivo. Consistent with this, current 
evidence suggests that pro-apoptotic factors linked with the ER-stress pathway, PUMA 
and BAX, play key roles in the modulation of neuronal death triggered by Aβ stress 
(Akhter et al., 2014; Feng et al., 2014; Kudo et al., 2012).  
A growing body of work suggests that the UPR is robustly activated in PD and ALS in 
vivo, although its involvement as a deleterious component in the progression of disease is 
controversial (Kikuchi et al., 2006; Hoozemans et al., 2007; Atkin et al., 2008; Sun et al., 
2013). As suggested previously, ATF4 was associated with a pro-death role in AD 
whereas its role in PD seems to favor a protective function. For example, ATF4 was 
detected in human post-mortem midbrain sections, and ATF4 knockdown sensitized 
neuronal cells to MPP+ due to a lack of Parkin expression, a transcriptional target of 
ATF4 (Bouman et al., 2011; Sun et al., 2013). Another ATF member, ATF6α was 
recently shown to play a key role in the preservation of dopaminergic neurons against 
MPTP neurotoxicity in vivo (Egawa et al., 2011). Data from ATF6α-null mice exposed to 
chronic ER-stress in vivo suggests that ATF6α plays a key role in longevity by alleviating 
continuous stress (Wu et al., 2007). Additionally, knockdown of XBP1 within the adult 
mouse SNpc was found to induce extensive neurodegeneration, as evidenced by the 
pronounced reduction in dopaminergic neurons, the enhanced expression of ER 
chaperones and the pro-apoptotic factor, CHOP (Valdés et al., 2014). Conversely, 
overexpression of XBP1s into the mouse SNpc preserved dopamine-producing neurons 
challenged with a PD-inducing neurotoxin (Valdés et al., 2014). Taken together, these 
data suggest that consistent chaperone production throughout life, mediated by ATF6α 
and XBP1s, is essential for long-term survival.  
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Some recent findings have supported the notion that interference in chaperone signaling 
can trigger disease course. For instance, αS is known to be significantly enriched in 
human PD brains, and knock-in mice carrying a missense mutation (A53T) in αS showed 
a pronounced interaction between A53T αS and BiP, which is thought to sensitize 
neurons to ER-stress (Colla et al., 2012).  
The persistent activation of the UPR has been observed in autopsied ALS tissue and is 
suspected to precede disease onset and reduce survivability, as evidenced in ALS model 
mice, compared to mutant SOD1
G86R
-ATF4
-/-
 littermates (Atkin et al., 2008; Matus et al., 
2013). Moreover, both SOD1
wt
 and mutant SOD1 can localize to the ER however, only 
SOD1
G93A
 interacted with BiP, which facilitated the increased expression of pro-
apoptotic UPR factors detected in ALS transgenic mice (Kikuchi et al., 2006). Similarly, 
XBP1
-/-
-SOD
G86R
 mutant mice had greater longevity and showed a significant reduction 
in neuronal apoptosis in the ventral horn, compared to ALS transgenic control mice (Hetz 
et al., 2009). 
 
1.5.5 DNA damage and Chronic Neurodegenerative Disease 
Although the function of p53 is to prevent cellular transformation, p53 can be 
inappropriately activated in the central nervous system to modulate the death of post-
mitotic neurons (Haupt et al., 2003; Enokido et al., 1996; Sakhi et al., 1994). DNA strand 
breaks are a potent DNA damaging stimulus capable of inducing apoptosis, and have 
been detected in autopsied AD, PD and ALS tissues (Enokido et al., 1996; Mullaart et al., 
1990; Zhang et al., 1999; Fitzmaurice et al., 1996). A unifying factor linking DNA 
damage to chronic neurodegenerative illness is the persistent presence of ROS, a known 
modulator of genotoxic stress and a key component in neurodegenerative pathologies (Yu 
and Anderson, 1997; Andersen, 2004). For example, mitochondrial complex I 
dysfunction in PD leads to a surplus of O2
-
 production, a free radical capable of extensive 
DNA damage (Rowley and Halliwell, 1983; Perier and Vila, 2012). Moreover, p53 was 
found to be enriched in post-mortem human AD, PD, ALS brains, after traumatic brain 
injury, and in response to MPP+ and Aβ treatment in vitro (de la Monte et al., 1998; 
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Napieralski et al., 1999; Kitamura et al., 1997; Bernstein and O’Malley, 2013; Akhter et 
al., 2014). Studies employing the use of p53-knockout mice have demonstrated that 
apoptosis is reduced in models of excitotoxicity and ischemic neuronal injury, relative to 
wild type (Morrison et al., 1996; Crumrine et al., 1994).  A substantial body of work has 
shown that in neuronal systems, p53 effects its pro-apoptotic function through a PUMA-
BAX-mediated pathway (Cregan et al., 1999; Cregan et al., 2004; Steckley et al., 2007). 
This is supported by studies that have detected PUMA in ischemic brain tissue, and in 
vitro following exposure to Aβ, DNA damaging agents and MPP+, stimuli known to be 
p53-dependent (Reimertz et al., 2003; Cregan et al., 2004; Perier et al., 2007; Feng et al., 
2014; Steckley et al., 2007). Similarly, PUMA-deficient neurons show a complete 
attenuation of neuronal apoptosis triggered by a wide spectrum of neurotoxins, an 
observation that is not recapitulated in other BH3 knockout mice (Steckley et al., 2007; 
Wong et al., 2005; Bernstein et al., 2011). Although PUMA is a p53-target gene, some 
stressors are able to drive its expression regardless of p53 status, indicating the existence 
of p53-independent pathways (Han et al., 2001; Jeffers et al., 2003; Fricker et al., 2010). 
 
1.6 Acute Neuronal Injury 
Interrupted blood flow within the central nervous system can trigger rapid necrotic cell 
death in the core region of the insult, while the surviving post-ischemic tissues in the 
penumbral zone are vulnerable to apoptosis over an extended time frame. The occlusive 
nature of the insult reduces oxygen delivery, impairing ATP production, and the 
subsequent maintenance of ionic gradients that are essential to neuronal functioning. One 
key ion that becomes imbalanced is Ca
2+
, which leads to the asymmetrical distribution of 
Ca
2+
 within the intracellular compartment. Increased cytosolic Ca
2+
 levels facilitate 
exocytosis within presynaptic terminals leading to the release of glutamate, the most 
abundant excitatory neurotransmitter. Glutamate transmits its excitatory impulse by 
interacting with N-methyl-D-aspartate (NMDA) and α-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid (AMPA) receptors, enhancing Ca
2+
 influx. Supra-physiological 
concentrations of intracellular Ca
2+
 cause a myriad of deleterious effects collectively 
referred to as excitotoxicity. Excitotoxic neuronal death is thought to proceed via 
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necrosis, whereas the surviving peripheral post-ischemic tissue is susceptible to 
apoptosis. This appears to be linked to the presence of functional mitochondria in the 
peri-infarct region, an area of reduced oxygen saturation that maintains cellular 
respiration (Broughton et al., 2009). Interestingly, blocking NMDA receptors with MK-
801 did not reduce hypoxia-induced neuronal apoptosis (Halterman et al., 2008). 
Similarly, antagonizing caspase activity had little effect attenuating excitotoxic neuronal 
injury (Glassford et al., 2002).  NMDA receptor activation also leads to an interaction 
with neuronal Nitric Oxide Synthase (nNOS), which overproduces NO using infiltrated 
Ca
2+
 as a required substrate (Sattler et al., 1999). Disrupting the association of NMDA 
and nNOS has been shown to reduce neurotoxicity and improve stroke outcome (Sattler 
et al., 1999; Luo et al., 2014). 
Excessive cytosolic Ca
2+ 
also
 
exerts toxic effects at the mitochondria by permeabilizing 
the OMM, causing a breakdown in the ETS and ATP production, leading to energy 
failure. Escaping electrons transition to ROS, such as O2
- 
that can interact with nNOS-
generated NO to form the highly poisonous free radical, peroxynitrite (ONOO
-
) 
(Broughton et al., 2009). The importance of ROS in the modulation of ischemic tissue 
injury is well documented. For instance, a study involving transgenic mice that 
overexpressed the antioxidant enzyme, SOD1, showed reduced infarct volumes in a 
model of cerebral ischemia (Kinouchi et al., 1991). Conversely, mice lacking SOD1 
showed enhanced neuronal loss under similar conditions (Kim et al., 2002). Mitochondria 
also contain an essential flavoprotein, Apoptosis-Inducing Factor (AIF), which is capable 
of nuclear translocation and DNA fragmentation upon mitochondrial breakdown. The 
importance of AIF as a potent modulator of ischemic cell death has been demonstrated in 
vivo using Harlequin mutant mice, which express substantially reduced amounts of AIF 
(Culmsee et al., 2005). 
Although many cellular macromolecules are susceptible to ROS toxicity, the resulting 
genotoxic stress can potentiate ATP depletion via excessive activity of the DNA-damage 
sensing enzyme, Poly (ADP-ribose) Polymerase 1 (PARP-1). Indeed cerebral ischemia 
has been shown to potently induce DNA strand breaks (Chen et al., 1997). In order to 
facilitate DNA repair, PARP-1 utilizes the essential metabolic co-enzyme, NAD+, to 
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signal the recruitment of restorative enzymatic complexes. Diminishing levels of NAD+ 
indirectly impairs ATP production, further increasing energy failure (Pieper et al., 1999). 
Interestingly, PARP-1 knockout mice are resistant to excitotoxic neuronal death, and 
show a significant reduction in AIF nuclear translocation (Wang et al., 2004).  
Ischemic neuronal injury can also trigger ER-stress by disrupting Ca
2+
 handling through 
the Sarco-Endoplasmic Reticulum Ca
2+
-ATPase (SERCA) pump. For example, ONOO
-
 
can directly modify and inhibit SERCA activity, which leads to deregulated Ca
2+
 levels 
within the ER lumen (Gutiérrez-Martín et al., 2004). Impaired ER-Ca
2+
 homeostasis 
results in defective chaperone functioning, and protein folding deficits, culminating with 
ER-stress (Figure 1.6) (Ashby and Tepikin, 2001). The initial phase of ER-stress 
signaling involves a reduction in protein translation to prevent a potentially toxic 
overload of unfolded proteins within the ER. Indeed, it has been demonstrated that 
ischemic neuronal injury activates the PERK-P-eIF2α axis (Kumar et al., 2001). 
Moreover, knockout studies involving pro-apoptotic downstream effectors of the PERK 
pathway, ATF4 and CHOP, showed reduced tissue loss following ischemic insults 
(Lange et al., 2008; Tajiri et al., 2004). Conversely, the pharmacological induction of the 
ER chaperone, BiP, significantly reduced CHOP expression and cerebral infarct volume 
(Kudo et al., 2008). 
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Figure 1.6. Acute excitotoxic neuronal injury.  
Following stroke, oxygen delivery is impaired and as a consequence, ionic gradients are 
susceptible to fluctuations. One of the key ions that can perpetuate post-ischemic damage 
is calcium (Ca
2+
). Uncontrolled increases in cytosolic Ca
2+
 in the presynaptic terminal 
can facilitate exocytosis of glutamate, an abundant excitatory neurotransmitter. 
Glutamate is known to bind the NMDA receptor, located on the postsynaptic membrane, 
which triggers an influx of Ca
2+
. The NMDA receptor can also couple with neuronal 
Nitric Oxide Synthase (nNOS), which uses Ca
2+
 to overproduce the free radical, nitric 
oxide (NO). Ca
2+
 toxicity also permeabilizes the outer mitochondrial membrane, allowing 
the outflow of ROS such as O2
-
, due to disruptions in the ETS. The combination of NO 
and O2
-
 yields peroxynitrite (ONOO
-
), a harmful ROS that inhibits enzyme activity and 
induces DNA damage. One key target of ONOO
-
 modification is the enzymatic ER Ca
2+
 
pump, SERCA. Alterations in ER Ca
2+
 can induce ER-stress. Extensive genotoxic 
damage signals the DNA repair enzyme, PARP-1, which indirectly depletes ATP stores 
and recruits the mitochondrial protein, AIF. Excitotoxicity can lead to DNA 
fragmentation via AIF activity (Broughton et al., 2009; Servier medical art). 
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1.6.1 The BCL-2 Family and Acute Neuronal Injury 
The importance of apoptotic cell death as a critical pathway driving ischemic neuronal 
death was demonstrated in Bcl-2-depleted mice, which exhibited substantially larger 
infarct volumes compared to wild type (Hata et al., 1999). Conversely, gain-of-function 
mice overexpressing Bcl-2 were significantly protected when subjected to cerebral 
ischemia or TBI (Martinou et al., 1994; Raghupathi et al., 1998; Nakamura et al., 1999). 
In 2001, Plesnila and colleagues showed that BID knockout mice sustained reduced 
infarct volumes following an in vivo model of brain ischemia (Plesnila et al., 2001). 
Similarly, other BH3-only members, PUMA and BIM, were robustly expressed following 
ischemic neuronal damage and TBI (Kuan et al., 2003; Reimertz et al., 2003; Niizuma et 
al., 2009; Sabirzhanov et al., 2014). In a model of seizure-induced neuronal death, 
PUMA-depleted mice significantly resisted hippocampal damage, compared to littermate 
controls (Engel et al., 2010). Further, BAX-deficient mice showed significantly reduced 
caspase-3 activation and tissue loss in response to TBI and hypoxic-ischemic brain 
injury, relative to wild type (Gibson et al., 2001; Tehranian et al., 2008). Consistent with 
this, pharmacological antagonism of caspase activity has proven effective, a notion that 
was recapitulated in caspase-3 knockout mice (Endres et al., 1998; Le et al., 2002). 
Interestingly, active caspase-3 was identified in rodent brain tissue following seizures and 
TBI, and in the post-ischemic human brain (Henshall et al., 2000; Clark et al., 2000; 
Rami et al., 2003).  
Other studies have investigated targeted inhibition strategies in pathways downstream of 
mitochondrial permeabilization preceding caspase activation, which have produced 
similar results. For example, pharmacological inhibition of the apoptosomal complex 
member, caspase-9, significantly reduced infarct volume relative to untreated control 
mice (Mouw et al., 2002). Similarly, overexpression of APAF-1-interacting protein (AIP) 
into the rat brain strongly attenuated caspase-3 activation, and remarkably enhanced 
neuronal survival following cerebral ischemia (Cao et al., 2004). 
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1.7 Models of Neurodegeneration 
In order to understand the key signaling events leading to the induction of pro-apoptotic 
effectors at the cellular level, considerable attention has been focused on specific stress 
signals, in particular, DNA damage, oxidative dysfunction and ER-stress, to extrapolate 
their relative contribution to the progression of chronic neurodegenerative and ischemic 
injury models. Moreover, these stress pathways have been shown to robustly induce the 
expression of pro-apoptotic genes in neuronal cells (Ryu et al., 2002; Reimertz et al., 
2003; Lange et al., 2008; Cregan et al., 2004; Steckley et al., 2007). Consistent with this 
is the reliance upon de novo gene expression, which is required for DNA damage, ER- 
and oxidative stress-induced neuronal apoptosis (Nath et al., 1997; Morris and Geller, 
1996; Choi et al., 1999). 
1.7.1 DNA damage 
Since DNA strand breaks have been detected in post-mortem AD, PD and ALS tissues, 
extensive research has focused on the use of genotoxic stressors as tools to investigate the 
signaling mechanisms that perpetuate neuronal loss in vitro (Enokido et al., 1996, Morris 
and Geller, 1996; Cregan et al., 2004). For example, the DNA-damaging agents, 
Camptothecin (CPT) and Etoposide (ETP) have been shown to trigger DNA strand 
breaks and apoptosis in neuronal cells (Enokido et al., 1996; Morris and Geller, 1996).  
1.7.2 ER-stress 
It is widely accepted that ER- and oxidative stress are involved throughout the disease 
course of many neurodegenerative conditions (Andersen, 2004; Hetz and Mollereau, 
2014). Therefore, to dissect the individual contributions of ER dysfunction to cell death 
signaling, specific inhibitors of critical ER functions have been employed such as, 
Thapsigargin (TG) and Tunicamycin (TM). The ER is major cellular compartment for 
Ca
2+
 storage and any perturbations involving its trafficking can elicit apoptosis. TG 
inhibits the SERCA pump, which functions as a vital ER-Ca
2+
 intake mechanism 
(Treiman et al., 1998). Another essential ER function is the maintenance of proper 
protein folding and packaging, including any post-translational modifications. TM is a 
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glycosylation inhibitor that prevents the successful preparation of proteins, facilitating an 
accumulation of misfolded aggregates in the ER lumen (Duksin and Bornstein, 1977).  
1.7.3 Oxidative stress 
In vitro modeling of oxidative stress is largely focused on disrupting electron flow 
throughout the mitochondrial ETS, yielding the excessive production of ROS beyond the 
antioxidant buffering capacity. For example, MPP+ and rotenone are known to induce 
experimental Parkinsonism due their neurotoxicity in the SNpc through a mechanism 
involving the inhibition of mitochondrial complex I (Mizuno et al., 1987; Betarbet et al., 
2000). Alternatively, treatment with exogenous ROS donors such as, tert-butyl 
hydroperoxide (t-BH), H2O2 and arsenite, have been demonstrated to achieve similar 
results in neuronal systems (Wong et al., 2005; Steckley et al., 2007; Lin et al., 2007).  
1.7.4 Hypoxic stress 
Following acute neuronal injury triggered by an ischemic insult, the surviving tissue 
surrounding the infarct core is susceptible to apoptotic cell death. This is due to the 
reduced oxygen supply and the diminished capacity to generate ATP, making neuronal 
tissue in the penumbral zone sensitive to hypoxic stress. Although penumbral tissue is 
vulnerable to apoptosis, the presence of functional mitochondria allows the existing 
neuronal subpopulation some resistance to cell death and therefore, occurs over an 
extended time period. In this way, targeting the penumbral zone as a salvageable area 
following ischemic injury is an attractive prospect ideal for therapeutic consideration. In 
vitro modeling of delayed hypoxic neuronal apoptosis involves exposing primary cortical 
cultures to 0.5% O2(g) rather than the endogenous 3% O2(g) saturation, which yields a 
primarily apoptotic phenotype (Halterman et al., 2008; Halterman et al., 2010). 
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1.8 Rationale 
DNA damage, oxidative stress and ER-stress are key signaling pathways regulating 
neuronal death following both acute neuronal injury and chronic neurodegenerative 
diseases. This is thought to occur by shifting the balance between pro- and anti-apoptotic 
members of the Bcl-2 family, favoring an accumulation of pro-death BH3-only factors 
that are capable of inducing BAX, a critical convergence point in the apoptotic process. 
The delineation of the critical BH3-proteins involved in mediating ER- and oxidative 
stress-induced neuronal apoptosis is not currently resolved but may be related to ISR 
signaling. The ISR is central to a variety of cellular perturbations and initially manages a 
cytoprotective function favoring restoration, whereas prolonged activation of the ISR can 
result in apoptosis. A master regulator of the ISR is ATF4, a transcriptional regulator 
capable of inducing pro-survival and pro-death factors. However, its role and mechanism 
of action in regulating neuronal cell death remains unclear. 
1.8.1 Hypothesis 
Prolonged activation of the integrated stress response factor, ATF4, triggers neuronal 
apoptosis via the transcriptional regulation of pro-apoptotic Bcl-2 family proteins. 
 
1.8.2 Objectives 
1. Determine whether ATF4 is required for oxidative stress and ER-stress-induced 
neuronal apoptosis. 
2. Determine whether ATF4 regulates the expression of pro-apoptotic Bcl-2 family 
proteins in neurons during oxidative- and ER-stress. 
3. Determine whether the ISR regulates hypoxia-induced neuronal apoptosis. 
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Chapter 2 
2 Materials and Methods 
2.1 Animals 
P53 mice, Chop and Bax mice were obtained from Jackson Laboratories (Bar Harbor, 
ME), mice harbouring null mutation for Puma were generated in the laboratory of Dr. 
Andreas Strasser (WEHI, Victoria, Australia), ATF3-depleted mice were generously 
donated by Dr. Tsonwin Hai (Ohio State University, Columbus, OH), and mice carrying 
an ATF4 null mutation were obtained from Drs. Tim Townes and Joe Sun (University of 
Alabama at Birmingham, AL). Timed-pregnant CD1 and C57/BL6 mice were obtained 
from Charles River Laboratories (Sherbrooke, QC, CA). All transgenic strains were 
maintained on a C57BL/6 background and genotyped as previously described (Cregan et 
al., 1999; Fortin et al., 2001; Zinszner et al., 1998; Hartman et al., 2004; Masuoka and 
Townes, 2002; Villunger et al., 2003). Wildtype and knockout littermates (experimental 
mice) were generated by breeding heterozygous mice.  
2.2 Primary cortical cultures 
Cortical neurons were dissociated from E14.5-E15.5 male and female mouse embryos 
and cultured in Neurobasal media containing N2 and B27 supplements (Invitrogen, 
Burlington, ON) as previously described (Cregan et al., 2002). Drug treatments were 
initiated 4 days after plating. Stock solutions of the PERK inhibitor, GSK2606414 (EMD 
Millipore), tunicamycin (TM), thapsigargin (TG), camptothecin (CPT), and etoposide 
(ETP) were prepared in DMSO (all from Sigma Aldrich, Oakville, ON, Canada) and 
diluted in culture media immediately before adding to neuronal cultures. Stock solutions 
of sodium arsenite and N-acetyl cysteine (NAC) (both from Sigma), were prepared in 
water and diluted in culture media immediately before adding to neuronal cultures. 
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2.3 Hypoxic conditions 
After 7 days in vitro, healthy primary cortical neuron cultures were transferred to a 
humidified hypoxic glove box (Model No. HYGB 42”, Serial No. 054520, COY Lab 
Products, Grass Lake, MI, USA) and continuously exposed to 0.5% O2 and 5% CO2, 
while being maintained at 37
o
C. Control cultures were held in a standard incubator at 
37
o
C, while infused with 21% O2 (normoxic) and 5% CO2.  
2.4 Nucleofection 
Cortical neurons were transiently transfected using the Nucleofection system according to 
the manufacturers’ instructions (Amaxa Biosystems, Cologne, Germany). Briefly, 0.25µg 
of pGFP (as a reporter) and 0.75µg of either pcDNA3-CHOP, or pcDNA3 as an empty 
vector control, was added to freshly dissociated cortical neurons suspended in Amaxa 
Mouse Neuron Nucleofector solution (5x10
7
 cells/ml). The cell suspension was then 
electroporated with the Nucleofector device using programme setting O-05 and then cells 
were immediately transferred to tubes containing DMEM supplemented with 10% FBS. 
Neurons were plated at a cell density of 1x10
6
 cells/ml in DMEM/FBS and the following 
day the media was changed to standard Neurobasal media containing N2/B27 
supplements.  
2.5 Cell death determination 
Neuronal apoptosis was assessed by examining nuclear morphology in Hoechst 33258 
stained cells as previously described (Cregan et al., 2002). Briefly, neurons were fixed in 
4% paraformaldehyde (containing 0.2% picric acid in 0.1M phosphate buffer, pH 7.1) for 
30 minutes, washed in PBS and stained with Hoechst 33258 (0.25µg/ml) dye. Neurons 
were visualized by fluorescence microscopy and images were captured using a CCD 
camera (Q-imaging, Burnaby, BC, Canada) and Northern Eclipse software (Empix 
imaging, Mississauga, ON, Canada). The fraction of cells exhibiting an apoptotic nuclear 
morphology characterized by pyknotic and/ or fragmented nuclei containing condensed 
chromatin was scored by an individual blinded to the treatments. 
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2.6 Caspase-3 activity assay 
Neurons were harvested in caspase lysis buffer (10 mM Hepes, pH 7.4, 1 mM KCl, 1.5 
mM MgCl2, 1 mM DTT, 1 mM PMSF, 10% glycerol, 5µg/ml leupeptin and 2 µg/ml 
aprotinin) and 10 µg of protein was used in caspase-3-like activity assay as previously 
described (Cregan et al., 1999). Briefly, protein samples were added to caspase reaction 
buffer (25 mM Hepes, pH 7.4, 10mM DTT, 10% sucrose, 0.1 % CHAPS, and 10 µM 
caspase-3 substrate Ac-DEVD-AFC) and fluorescence produced by cleavage of Ac-
DEVD-AFC substrate was measured on a SpectraMax M5 spectrofluorimeter (excitation 
400 nm, emission 505 nm) over a 1 hour interval. Caspase activity is reported as ratio of 
fluorescence output in treated samples relative to corresponding non-treated controls.  
2.7 Quantitative reverse transcription-PCR 
RNA was isolated using Trizol reagent as per manufacturers’ instructions (Invitrogen) 
and RNA concentration was measured on a spectrophotometer.   Quantitative RT-PCR 
was performed using the QuantiFast SYBR Green RT-PCR kit (#204154, Qiagen, 
Mississauga, ON, Canada) and 20 ng of RNA as previously described (Steckley et al., 
2007). RT-PCR was carried out on a Chromo4 detection system (MJ Research/ Bio-Rad, 
Mississauga, ON, Canada) and changes in gene expression were determined using the 
∆(∆Ct) method using the ribosomal S12 transcript for normalization. Data is reported as 
fold increase in mRNA levels in treated samples relative to corresponding untreated 
control samples for each transcript. All PCRs exhibited high amplification efficiencies 
(>90%) and the specificity of the PCR products were confirmed by sequencing. Primer 
sequences used for gene specific amplification are available upon request.  
2.8 XBP1 splicing 
RNA was isolated using Trizol reagent as per manufacturers’ instructions (Invitrogen) 
and RNA concentration was measured on a spectrophotometer. Semi-quantitative RT-
PCR was performed using the OneStep RT-PCR kit (#210212, Qiagen, Mississauga, ON, 
Canada) and 20 ng of RNA was reverse-transcribed into cDNA. RT-PCR was carried out 
using an Eppendorf AG Mastercycler 22331 (Hamburg, Germany). Full length Xbp1 and 
Xbp1s were resolved by electrophoresis using a 2% agarose gel and visualized using 
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ethidium bromide and UV light. S12 was used as a loading control. Primer sequences are 
available upon request. 
2.9 Western blot analysis 
Whole cell extracts (50 µg protein) were loaded and separated on 10-12% SDS-
polyacrylamide gels and transferred onto nitrocellulose membranes. Blots were probed 
with primary antibodies to ATF4/CREB-2x (Santa Cruz, 1:5000), Gadd153/CHOP (Santa 
Cruz, 1:500), ATF3 (Santa Cruz, 1:200), ATF6 (Imgenex, 1:500), p53 (Cell Sign, 
1:1000), BAX (Santa Cruz, 1:500), PUMA (Sigma, 1:500), Cleaved Caspase-3 (Cell 
Sign, 1:1000), total eIF2α (Cell Sign, 1:1000), Phospho-eIF2α (Invitrogen, 1:1000) and 
total PERK (Sigma, 1:1000) in blocking buffer overnight. Membranes were washed in 
TBST buffer, probed with HRP secondary (1:10,000), and immunoreactive bands 
proteins were visualized using SuperSignal ECL (Pierce). Blots were stripped and 
reprobed for GAPDH (Cell Sign, 1:5000), α-tubulin (Cell Sign, 1:5000), or actin (Santa 
Cruz, 1:10,000) as loading controls.  
2.10 Chromatin Immunoprecipitation (ChIP) assay  
Neuronal cultures (2x10
7
 cells) were crosslinked with 0.5% formaldehyde and then 
harvested in SDS lysis buffer and sonicated to fragment DNA. Extracts were incubated 
with antibodies to ATF4/CREB-2 (C-20X, Santa Cruz), Gadd153/CHOP (sc-575, Santa 
Cruz), or rabbit IgG control and immunoprecipitated with protein-G sepharose beads. 
Immunocomplexes were eluted, decrosslinked at 65ºC, and DNA was recovered by 
phenol-chloroform extraction. Quantitative PCR was performed using the Quantitect 
SYBER Green PCR kit according to manufacturer’s instructions (Qiagen, Mississauga, 
ON, Canada). Relative DNA binding of ATF4 and CHOP was determined as the ∆Ct 
values between treated and untreated samples immunoprecipitated with the same 
antibody. ∆Ct values were corrected for any changes in nonspecific interactions as 
determined by corresponding IgG pulldown samples and data is reported as fold 
enrichment (2
∆Ct
) in DNA binding. Primer sequences used for amplification of the 
PUMA promoter were 5’-CTGTCCCCACGCTGTC (forward) and 5’-
GCTTGCTTGCTGGTGTCG (reverse) and for the CHOP promoter were 5’-
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GACAAGTTCAGGAAGGACAGC (forward) and 5’-CGGAGGAGGTGAGTGAGTCA 
(reverse). 
2.11 Data analysis 
Data is reported as mean and SEM. The value n represents the number of independent 
neuron cultures or number of embryos of indicated genotype from which independent 
neuron cultures were prepared involving at least 3 independent experiments. Differences 
between groups were determined by ANOVA and post hoc Tukey test and were 
considered statistically significant when p<0.05.  
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Chapter 3 
3 Results 
The gene expression experiments represented in Figures 3.10a, b and Fig. 3.12b, c were 
performed concurrently but are presented separately to enhance the flow of the results. 
The cell death assessments represented in Figures 3.11a, b and Fig. 3.14b, c are depicted 
in the same way. 
3.1 ER and oxidative dysfunction trigger neuronal apoptosis 
through a PUMA-BAX-mediated pathway that is 
activated independently of p53 
Oxidative dysfunction and ER-stress are known to trigger apoptosis via both p53-
dependent and -independent pathways that require the intrinsic/mitochondrial Bax-
mediated pathway (Li et al., 2006; Wei et al., 2001; Smith and Deshmukh, 2007; Fricker 
et al., 2010; Wong et al., 2005; Bernstein et al., 2011; Perier et al., 2007; Steckley et al., 
2007; Wang et al., 2007). Pro-apoptotic family members of the Bcl-2 family, BH3-only 
proteins, serve as direct or indirect regulators of BAX-mediated apoptosis (Youle and 
Strasser, 2008). Previous work has indicated that BH3-only members, Puma, Bim and 
Noxa, are induced following exposure to several inducers of ER- and oxidative stress 
(Reimertz et al., 2003; Li et al., 2006; Puthalakath et al., 2007; Steckley et al., 2007; 
Bernstein et al., 2011; Wong et al., 2005). However, only the deletion of PUMA was 
sufficient to effectively mitigate neuronal cell death in response to oxidative dysfunction 
(Steckley et al., 2007). Since ER- and oxidative stress can induce PUMA expression 
independently of p53, and because PUMA is a dominant regulator of Bax-mediated 
neuronal apoptosis, we sought to determine the p53-independent signaling pathways 
regulating its induction.  
To do so, we examined the expression of Puma in primary cortical neuron cultures 
exposed to sodium arsenite (arsenite), an oxidative stressor, and thapsigargin (TG), an 
inhibitor of the SERCA pump. We found that Puma was robustly expressed following 
exposure to arsenite, and to the ER-stressor, TG (Fig. 3.1a). Similarly, we detected 
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PUMA protein levels were strongly accumulated following 8h of arsenite treatment (Fig. 
3.1b). We also detected the enrichment of PUMA protein that was maintained after 20h, 
and correlated with a marked enhancement of cleaved caspase-3, an executioner caspase 
associated with the late stages of apoptosis (Fig. 3.1c). However, in the ER-stress 
paradigm this was only evident in BAX-depleted neurons, presumably due to the rapid 
cell death occurring in wild type neurons (Fig. 3.1d) (Galehdar et al., 2010).  
To ascertain whether the increase of caspase-3 cleavage enhanced apoptosis, we 
assessed the appearance of chromatin condensation and nuclear fragmentation and 
observed that arsenite and TG increased the incidence of condensed chromatin, indicative 
of a primarily apoptotic phenotype (Fig. 3.1e-f). The cell death response was quantified 
and demonstrated that arsenite or TG-treated neuronal cultures showed a substantial 
increase in the fraction of cells exhibiting apoptotic nuclei (Fig. 3.1g).  
We next assessed the importance of Bax as a key gateway to the apoptotic process 
by quantifying the appearance of pyknotic nuclei (Fig. 3.2a) and caspase-3 activity (Fig. 
3.2b) in BAX-deficient neurons exposed to ER-stress. Similarly, we observed that BAX-
deletion strongly attenuated caspase-3 activation (Fig. 3.2c) and neuronal apoptosis (Fig. 
3.2d) in response to arsenite stress, relative to BAX
+/- 
littermates.  
Consistent with the diminished levels of caspase-3 activation and neuronal 
apoptosis detected in BAX-null neurons, we found that PUMA-deficiency similarly 
abrogated the expression of active caspase-3 (Fig. 3.3a) and neuronal apoptosis (Fig. 
3.3b) following exposure to arsenite stress. Interestingly, PUMA-depleted neurons treated 
with TG or the N-glycosylation inhibitor, tunicamycin (TM), showed a drastic reduction 
(~40%) in neuronal apoptosis extending up to 48h (Appendix A Figure 1). Although BIM 
is known to be up-regulated following arsenite treatment and ER-stress, BIM-depletion 
does not recapitulate the protective phenotype observed in PUMA-null neurons (Wong et 
al., 2005; Galehdar et al., 2010). Taken together, our results suggest that PUMA plays a 
dominant role in the modulation of neuronal apoptosis in response to ER dysfunction and 
arsenite stress. 
39 
 
We and others have previously demonstrated that the transcriptional activator p53 
is essential for PUMA induction and neuronal apoptosis induced by DNA damage 
(Cregan et al., 2004; Wyttenbach and Tolkovsky, 2006; Uo et al., 2007). Accordingly, we 
next investigated whether a p53-PUMA pathway is also involved in ER-stress-mediated 
neuronal death. To address this we first determined the expression of p53 protein 
following DNA damage and ER-stress. Interestingly, p53 was not stabilized by ER-stress 
whereas p53 was gradually accumulated in response to the DNA damaging agent, 
camptothecin (CPT) (Appendix B Figure 1). 
Finally we examined Puma expression in p53
+/+
 and p53
-/-
 cortical neurons 
following treatment with the ER stressors TM and TG. Puma mRNA levels were 
increased by the ER stressors to a similar extent in p53
+/+
 and p53
-/-
 neurons while, as 
expected, DNA damage-induced Puma expression was abolished in the absence of p53 
(Appendix B Figure 2). Moreover, we demonstrated that neurons lacking p53 were 
equally sensitive to neuronal apoptosis as wild type cultures, following exposure to TM 
(Galehdar et al., 2010).  
Taken together, current evidence suggests that ER-stress induces neuronal 
apoptosis through a PUMA-mediated pathway that is activated independently of p53.   
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Figure 3.1. ER dysfunction and arsenite stress induce key hallmarks of 
apoptosis. 
A. Total RNA was isolated from wild type cortical neurons 8h post-treatment with 5 
μM sodium arsenite (NaAsO2
-,oxidative stress) or 3 μM thapsigargin (TG, ER-stress), 
as a positive control, and mRNA level of Puma was determined by qRT-PCR. 
Expression was normalized to s12 mRNA levels and is reported as fold increase 
relative to untreated control cells (n=3; **p < 0.01). B. Wild type cortical neurons 
were exposed to 5 μM NaAsO2
-, and after 8h, protein levels of PUMA and the 
loading control, Actin, were assessed as a whole cell extract by Western blot analysis. 
C. Wild type cortical neurons were exposed to 5 μM NaAsO2
-, and after 20h, protein 
levels of PUMA, Cleaved Caspase-3, and the loading control, Actin, were assessed as 
a whole cell extract by Western blot analysis. D. Bax-deficient cortical neurons were 
treated with TM and Puma protein was assessed by Western blot at 24 hours. E-F. 
Representative panels of control (left panel), 5 µM NaAsO2
--treated (middle panel) 
and TG-treated (right panel) wild type cortical neurons fixed and stained with 
Hoechst stain (1:1000) 24h post-treatment. G. The fraction of apoptotic cells (red 
arrow) showing chromatin condensation and fragmented nuclei relative to healthy 
cells (green arrow) was determined (400X magnification). 
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Figure 3.2. ER- and arsenite stress promote neuronal apoptosis through a 
BAX-mediated pathway. 
A. Cortical neurons derived from Bax wild type and knockout littermates were 
treated with 3 μM TG, 4 μM TM, and the fraction of apoptotic cells was determined 
at 30h by assessing nuclear morphology following Hoechst staining (n≥3; 
***p<0.001). B. Bax wild type and knockout cortical neurons were treated with ER 
stressors as above. Cell lysates obtained 20 hours after treatment were assayed for 
caspase-3 activity (n≥3; ***p<0.001). C. BAX+/- and BAX-/- cortical neurons were 
treated with 5 µM NaAsO2
-, and after 20h, protein levels of BAX, cleaved caspase-3 
(cCasp3), and the loading control, Actin, were assessed as a whole cell extract by 
Western blot analysis. D. Representative panels of BAX+/- and BAX-/- cortical neurons 
fixed and stained with Hoechst stain (1:1000) 24h post-treatment with 5 µM NaAsO2
-
. The fraction of apoptotic cells (red arrow) showing chromatin condensation and 
fragmented nuclei relative to healthy cells (green arrow) was determined (n=3; 
***p<0.001) (400X magnification). 
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Figure 3.3. PUMA is critical for neuronal apoptosis triggered by arsenite 
stress. 
A. PUMA+/+ and PUMA-/- cortical neurons were treated with or without 5 μM NaAsO2
-
, and after 20h, protein levels of PUMA, Cleaved caspase-3, and the loading control, 
Actin, were assessed as a whole cell extract by Western blot analysis. B. 
Representative panels of PUMA+/+ and PUMA-/- cortical neurons 24h post-treatment 
with 5 μM NaAsO2
-, were fixed and stained with Hoechst stain (1:1000). The fraction 
of apoptotic cells (red arrow) showing chromatin condensation and fragmented nuclei 
relative to healthy cells (green arrow) was determined (n=3; ***p < 0.001) (400X 
magnification). 
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3.2 ER-dysfunction and arsenite stress differentially activate 
components of the UPR 
Since PUMA plays a critical role in mediating arsenite-induced neuronal death and 
arsenite is known to induce PUMA independently of p53 (Fricker et al., 2010), we next 
surveyed other stress pathways to determine their involvement in the regulation of 
PUMA. Indeed, previous reports have indicated that arsenite can induce the expression of 
genes associated with the UPR in non-neuronal cells (Jiang et al., 2007; Weng et al., 
2013). Therefore, we examined the activation of the UPR by arsenite, in wild type 
cortical cultures. Firstly, we determined the activation of the ER-stress sensor, IRE1α, 
which can be accomplished by measuring the degree of Xbp1 processing from its 
unspliced form to its transcriptionally active, spliced variant. Using semi-quantitative 
PCR, we showed that TG but not arsenite induced Xbp1 processing to its active, spliced 
form (Fig. 3.4a). Second, we analyzed the expression of the ER chaperone, BiP/Grp78, 
by qRT-PCR and observed a disparate expression pattern, where BiP/Grp78 was 
differentially activated by ER-stress but not by arsenite treatment (Fig. 3.4b).  
Conversely, when we determined ATF6 activation, we found a significant up-
regulation of Atf6 mRNA, by qRT-PCR, in response to oxidative stress (*p < 0.05) and 
ER-stress (*p < 0.05; **p < 0.01) (Fig. 3.5a-b). We then confirmed the activation of 
ATF6α protein by indicating the fraction of full-length ATF6α and that of the 
transcriptional activator, protease cleaved ATF6αf (Fig. 3.5c).  
Finally, we evaluated the activation of the PERK-eIF2α pathway by determining 
the gene expression changes of its key downstream targets:  Atf3, Atf4 and Chop. All 
three UPR-associated genes were profoundly induced in response to arsenite and TG 
treatment, as measured by qRT-PCR (Fig. 3.6a). We then performed a time-course 
experiment for up to 8 hours measuring the protein expression of ATF3, ATF4, CHOP, 
P-eIF2α/eIF2α. Because PUMA expression was strongly induced 8 hours post-treatment, 
we reasoned that the critical transcription factor(s) necessary for its induction would be 
required within that limited time frame. In support of this, we found an initial increase in 
P-eIF2α at 1h that was persistent, indicating general translational arrest (Fig. 3.6b). 
However, certain mRNAs such as Atf4 and Chop are known to be preferentially 
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translated under these conditions (Vattem and Wek, 2004; Palam et al., 2011). Following 
the detection of P-eIF2α, at 2 hours we found that arsenite treatment markedly enhanced 
ATF4 levels at 2h, followed by ATF3 at 4 hours, and CHOP at 8 hours. The intensity of 
their expression was similar in magnitude to TG treatment.  
In summary, we found that arsenite triggers a selective activation of the UPR 
leading to the induction of ATF6α and downstream targets of the PERK-eIF2α pathway, 
ATF3, ATF4 and CHOP. Conversely, Xbp1 splicing and the expression of BiP/Grp78 
were not detected under these conditions. 
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Figure 3.4. Xbp1 mRNA splicing and BiP expression are activated by ER-
stress but not by arsenite. 
A. Total RNA was isolated from wild type cortical neurons at 2h, 4h and 8h post-
treatment with 5 μM NaAsO2
-
 or 3 μM TG, and mRNA levels of unspliced (240bp) 
and spliced (218bp) Xbp1 mRNA (blue arrow) were determined by semi-quantitative 
RT-PCR. Expression was normalized to s12 mRNA (350bp) levels (n=3). B. Total 
RNA was isolated from wild type cortical neurons 8h post-treatment with 5 μM 
NaAsO2
- or 3 μM TG, as a positive control, and mRNA levels of ER chaperone, 
BiP/Grp78 was determined by qRT-PCR. Expression was normalized to s12 mRNA 
levels and is reported as fold increase relative to untreated control cells (n=3; **p < 
0.01).  
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Figure 3.5. The ATF6 arm of the UPR is activated by ER-stress and in 
response to arsenite toxicity. 
A-B. Total RNA was isolated from wild type cortical neurons at 2h, 4h and 8h post-
treatment with 5 μM NaAsO2
-
  (green panel) or 3 μM TG (orange panel), then mRNA 
levels of Atf6 were determined by qRT-PCR. Expression was normalized to s12 
mRNA levels and is reported as fold increase relative to untreated control cells (n=3; 
*p < 0.05; **p < 0.01). C. Wild type cortical neurons were exposed to 5 μM NaAsO2
-
 
or 3 μM TG, and after 8h, ATF6α and ATF6αf protein levels and the loading control, 
GAPDH, were assessed as a whole cell extract by Western blot analysis. 
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Figure 3.6. Downstream proteins of the PERK branch of the UPR are 
similarly activated by ER- and arsenite stress. 
A. Total RNA was isolated from wild type cortical neurons 8h post-treatment with 5 
μM NaAsO2
-
 or 3 μM TG and mRNA levels of Chop, Atf4 and Atf3, were determined 
by qRT-PCR. Expression was normalized to s12 mRNA levels and is reported as fold 
increase relative to untreated control cells (n=3; *p < 0.05; ***p < 0.001). B. Wild 
type cortical neurons were exposed to NaAsO2
-
 and after 1h, 2h, 4h and 8h, or after 
8h of TG treatment, and protein levels of ATF4, CHOP, ATF3, P-eIF2α/total eIF2α, 
and the loading control, Actin, were assessed as a whole cell extract by Western blot 
analysis. 
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3.3 Arsenite and ER-stress activate ATF4 expression by 
different mechanisms 
We then defined whether arsenite triggers the activation of PERK to maintain ATF3, 
ATF4 and CHOP expression. This can be accomplished by monitoring changes in the 
electrophoretic mobility of PERK as an indication of P-PERK, with an antibody directed 
against the C-terminus (Bertolotti et al., 2000). As expected, TG induced an appreciable 
shift in PERK mobility whereas the PERK inhibitor (Pi), GSK2606414, and untreated 
control were indifferent, after 8h. The supershift of PERK was abolished when TG was 
paired with Pi, resembling untreated control or Pi alone (Fig. 3.7a). Similar to previous 
work using non-neuronal cells (Harding et al., 1999), PERK activation was detected only 
in neuronal lysates treated with TG after 4 and 8h, relative to untreated control or 
arsenite-treated samples (Fig. 3.7b). We found that ATF3, ATF4 and CHOP protein 
levels were attenuated by TG in combination with Pi, relative to the profound induction 
by TG alone. Conversely, we observed that ATF3, ATF4 and CHOP were similarly 
expressed in response to arsenite and Pi, or arsenite stress alone (Fig. 3.7c). These 
findings indicate that oxidative dysfunction mediated by arsenite stress triggers a PERK-
independent mechanism to robustly accumulate ATF3, ATF4 and CHOP. 
3.3.1 N-acetyl cysteine (NAC) reduces ATF4 levels induced by 
oxidative stress but not by ER dysfunction 
Since we have previously demonstrated that both oxidative and ER-dysfunction lead to 
the enrichment of ATF4 in neuronal cells, we addressed whether or not both stresses 
share a common pathway regulating ATF4 expression. To do this we pretreated cortical 
neurons with the antioxidant, N-acetyl cysteine (NAC), 1h prior to arsenite or TG 
treatment to evaluate the potential disparity of each pathway. We observed that the 
addition of NAC does not activate ATF4 protein expression, while exposure to arsenite or 
TG robustly accumulated ATF4 levels. However, pre-incubation with NAC suppressed 
arsenite-mediated ATF4 expression, while having only a mild effect on ATF4 levels 
induced by ER dysfunction (Fig. 3.8). These data suggest the presence of mutually 
exclusive signaling mechanisms by which unique cellular stresses are interpreted. 
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Figure 3.7. Arsenite activates ATF3, ATF4 and CHOP independently of 
PERK. 
A. Wild type cortical neurons were pre-treated with or without 1 μM of the PERK 
inhibitor, GSK2606414, (Pi) for 1h, and then in conjunction with 3 μM TG or 3 μM 
TG alone, and after 8h, protein levels of PERK and the loading control, Actin, were 
assessed as a whole cell extract by Western blot analysis. B. Wild type cortical 
neurons were treated with or without 5 μM NaAsO2
-
 or 3 μM TG, and after 4 and 8h, 
protein levels of PERK and the loading control, Actin, were assessed as a whole cell 
extract by Western blot analysis. C. Wild type cortical neurons were pre-treated with 
or without 1 μM Pi for 1h, followed by 5 μM NaAsO2
-
   or 3 μM TG, and after 8h, 
protein levels of ATF4, CHOP, ATF3, and the loading control, Actin, were assessed 
as a whole cell extract by Western blot analysis. n.s. = non-specific. 
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Figure 3.8. NAC attenuates ATF4 expression in response to oxidative stress 
but not ER dysfunction. 
Wild type cortical neurons were pre-treated with or without 5 mM N-acetyl cysteine 
(NAC) for 1h prior to additional treatment with or without 5 μM NaAsO2
- (Na) for 
1h, 4h and 8h, or after 8h with or without 3 μM TG. Whole cell lysates were collected 
at the indicated times and levels of ATF4 and the loading control Actin, were 
assessed by a Western blot. 
 
 
 
 
 
 
 
 
 
59 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
60 
 
3.4 ATF4 regulates CHOP and ATF3 during arsenite stress 
and ER dysfunction 
Since ATF3, ATF4 and CHOP are transcriptional regulators, we aimed to show the 
hierarchy of their induction using gene-specific knockout mice. We found that ATF3-
deficiency does not contribute to the regulation of ATF4 or CHOP, in response to 
arsenite or TG treatment (Fig. 3.9a). Moreover, CHOP-deletion did not reduce ATF4 
protein levels due to arsenite or TG exposure. However, we did notice the differential 
regulation of ATF3 by CHOP, which was stress-dependent. We observed no difference 
between ATF3 protein expression in CHOP
+/+
 or CHOP
-/-
 neurons treated with arsenite 
stress however we detected an appreciable reduction of ATF3 protein in CHOP-depleted 
neurons treated with TG, relative to their wild type counterparts (Fig. 3.9b). Interestingly, 
both CHOP and ATF3 protein levels were completely abolished in arsenite- and TG-
treated ATF4
-/-
 neurons, relative to wild type (Fig. 3.9c).  
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Figure 3.9. Arsenite stress and ER dysfunction activate ATF3 and CHOP in 
an ATF4-dependent manner. 
A. ATF3+/+ and ATF3-/- cortical neurons were exposed to 5 μM NaAsO2
- or 3 μM TG, 
and after 4h and 8h, protein levels of ATF4, CHOP, ATF3, P-eIF2α/total eIF2α, and 
Actin, as a loading control, were assessed as a whole cell extract by Western blot 
analysis. B. CHOP+/+  and CHOP-/- cortical neurons were exposed to 5 μM NaAsO2
- 
or 3 μM TG, and after 4h and 8h, protein levels of ATF4, ATF3, P-eIF2α/total eIF2α, 
and Actin, as a loading control, were assessed as a whole cell extract by Western blot 
analysis. C. ATF4+/+ and ATF4-/- cortical neurons were exposed to 5 μM NaAsO2
- or 
3 μM TG, and after 4h and 8h, protein levels of ATF4, CHOP, ATF3, and α-tubulin, 
as a loading control, were assessed as a whole cell extract by Western blot analysis.           
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3.5 ATF4 promotes oxidative-stress-induced PUMA 
expression and neuronal apoptosis 
Because ATF3, ATF4 and CHOP have been implicated as pro-death transcription factors 
(Hartman et al., 2004; Silva et al., 2005; Lange et al., 2008; Han et al., 2013), we 
examined their potential roles as regulators of PUMA expression in response to arsenite 
toxicity. Interestingly, both ATF4 and CHOP have been shown to transactivate the 
PUMA promoter, in non-neuronal cells (Cazanave et al., 2010; Qing et al., 2012). 
However, we found that only ATF4 deletion significantly attenuated Puma mRNA levels 
(*p < 0.05), relative to wild type, whereas ATF3 or CHOP depletion did not significantly 
reduce Puma expression (Fig. 3.10a-c). Moreover, ATF4-deficiency resulted in a 
profound reduction of PUMA protein, relative to wild type neurons exposed to 8h of 
arsenite stress (Fig. 3.10d). This effect was persistent and mitigated both PUMA and 
caspase-3 cleavage following 20 hours of arsenite exposure (Fig. 3.10e). Conversely, 
ATF3 or CHOP-depleted neurons treated with arsenite showed a similar degree of 
cleaved caspase-3, relative to wild type and heterozygous littermates (Fig. 3.10f-g). 
Additionally, only ATF4 null cortical cultures showed significantly reduced levels of 
apoptotic cell death, compared to wild type, when challenged with arsenite stress for 24 
hours (n=3; ***p < 0.001), whereas ATF3 or CHOP-deficiency did not attenuate 
arsenite-induced apoptosis (Fig. 3.11a-c). Together, our results indicate that ATF4 plays 
a key role in modulating PUMA expression, caspase-3 activation, and neuronal cell death 
mediated by arsenite stress. 
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Figure 3.10. ATF4 drives PUMA expression and caspase-3 cleavage during 
arsenite stress. 
A. Total RNA was isolated from ATF4+/+ and ATF4-/- 8h post-treatment with 5 
µM NaAsO2
- and mRNA levels of Puma were determined by qRT-PCR. 
Expression was normalized to s12 mRNA levels and is reported as fold increase 
relative to untreated control cells (n=4; *p < 0.05). B. Total RNA was isolated 
from ATF3+/+ and ATF3-/- neurons 8h post-treatment with 5 µM NaAsO2
-, and 
mRNA levels of Puma were determined by qRT-PCR. Expression was 
normalized to s12 mRNA levels and is reported as fold increase relative to 
untreated control cells (n=3). C. Total RNA was isolated from CHOP+/- and 
CHOP-/- neurons 8h post-treatment with 5 µM NaAsO2
-, and mRNA levels of 
Puma were determined by qRT-PCR. Expression was normalized to s12 mRNA 
levels and is reported as fold increase relative to untreated control cells (n=3). D. 
ATF4+/+ and ATF4-/- cortical neurons were treated with or without 5 μM NaAsO2
- 
for 8h, and protein lysates were assessed for levels of ATF4, PUMA, and Actin, 
as a loading control, by Western blot analysis. E. ATF4+/+ and ATF4-/- cortical 
neurons were treated with or without 5 μM NaAsO2
- for 20h, and protein lysates 
were assessed for levels of ATF4, PUMA, cleaved caspase-3, and Actin, as a 
loading control, by Western blot analysis. F. ATF3+/+ and ATF3-/- cortical neurons 
were treated with or without 5 μM NaAsO2
- for 20h, and protein lysates were 
assessed for levels of ATF3, cleaved caspase-3, and Actin, as a loading control, 
by Western blot analysis. G. CHOP+/- and CHOP-/- cortical neurons were treated 
with or without 5 μM NaAsO2
- for 20h, and protein lysates were assessed for 
levels of CHOP, cleaved caspase-3, and Actin, as a loading control, by Western 
blot analysis.  
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Figure 3.11. ATF4-deficiency reduces arsenite-mediated neuronal apoptosis. 
A-C. The fraction of apoptotic cells showing chromatin condensation and 
fragmented nuclei relative to healthy cells was determined in ATF4, ATF3 or 
CHOP-deficient cortical neurons (n=3; ***p < 0.001). Representative panels of 
wild type, heterozygous and ATF3-, CHOP- or ATF4-null cortical neurons fixed 
and stained with Hoechst stain (1:1000) 24h post-treatment with 5 µM NaAsO2
-. 
The red arrow indicates apoptotic nuclei, and the green arrow indicates healthy 
nuclei (400X magnification).  
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3.6 ATF4 regulates PUMA expression via an indirect 
mechanism during ER-stress 
We have previously indicated that a transcriptional activator other than p53 is required 
for Puma induction during ER-stress (Appendix B Figure 2). The transcription factor 
ATF4 has been implicated in ER-stress, however its functional role in the ER-stress 
response and relevance to cell death remain unclear. Indeed it has been shown that ATF4 
can favor a pro-survival or a pro-death response in a variety of experimental systems 
(Lange et al., 2008; Armstrong et al., 2010; Harding et al., 2003; Jiang et al., 2007). 
Interestingly, ATF4 was recently demonstrated to transactivate the PUMA promoter 
following nutrient deprivation, in non-neuronal cells (Qing et al., 2012). Accordingly, we 
examined the potential role of ATF4 in ER-stress-mediated death pathways.  Indeed, we 
observed a robust induction in ATF4 protein levels following treatment with the ER 
stressor TM, but not in response to the DNA damaging agent, CPT. Conversely, p53 was 
enriched only after exposure to CPT and not TM (Fig. 3.12a). We next examined the 
endogenous role of ATF4 using gene-specific knockout mice. As shown in Figure 3.12b, 
Puma induction and neuronal apoptosis (Fig. 3.12c) induced by TG were significantly 
reduced in ATF4-deficient neurons as compared to wild type cultures. Thus, ATF4 
promotes Puma induction and neuronal death during ER dysfunction, whereas p53 is 
expendable (Galehdar et al., 2010).  
We next examined whether ATF4 can activate the PUMA promoter. To address this we 
generated reporter constructs to identify the ATF4 responsive region present in the 
PUMA promoter, which corresponded to a region ~90-210 base pairs upstream of the 
transcription start site of Puma (Galehdar et al., 2010). Therefore, we examined this 
region for potential ATF4 binding sites using the Genomatix promoter analysis software 
and identified a conserved element exhibiting significant homology to the consensus 
ATF/CRE binding sequence and located approximately 25bp downstream of the 
previously identified p53 binding site (Fig. 3.13a) (Yu et al., 2001; Han et al., 2001). To 
determine whether ATF4 binds to the PUMA promoter during ER-stress in situ we 
performed quantitative chromatin immunoprecipitation (ChIP) assays using PCR primers 
flanking the ATF4 responsive region and encompassing the putative ATF4-binding sites. 
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Curiously, we did not detect an increase in ATF4 binding in this region following either 
DNA damage or ER-stress treatments. However, ATF4 binding was significantly 
enriched at a previously described ATF4 response element located in the CHOP promoter 
(Ma et al., 2002) confirming that the ATF4 ChIP assay worked (Fig. 3.13b). These results 
suggest that ATF4 likely regulates Puma expression during ER-stress via an indirect 
mechanism. 
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Figure 3.12. ATF4 facilitates ER-stress-induced neuronal apoptosis. 
A. Wild type cortical neurons were treated with 10 µM camptothecin or 4 µM 
tunicamycin (TM) for 1h, 2, 4h and 8h, and protein levels of ATF4, p53 and the 
loading control, GAPDH, were then assessed by Western blot. B. Cortical 
neurons derived from ATF4
+/+
 and ATF4
-/-
 littermates were treated with the ER 
stressor TG (3 µM), and RNA was extracted after 8 hours. Puma mRNA levels 
were quantified by real-time PCR and are reported as fold increase over 
corresponding untreated controls (n=4; *p<0.05). C. Cortical neurons derived 
from ATF4
-/-
 embryos and wild type littermates were treated with the TG (3 µM). 
At the indicated time, neurons were stained with Hoechst dye 24h after treatment 
and the fraction of apoptotic (red arrow) and healthy (green arrow) cells was 
determined by assessing nuclear morphology (400x magnification) (n=3; 
***p<0.001). 
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Figure 3.13. ATF4 does not directly activate the Puma promoter during ER-
stress. 
A. Schematic of the Puma promoter showing the location of the putative 
ATF/CRE and p53-binding sites. Arrows indicate the approximate positions of 
the PCR primers used in the ChIP assays. B. Cortical neurons were treated with 
DNA damage, CPT (10 µM) or ER-stressors, TM (4 µM) or TG (3 µM), and 
binding of ATF4 was assessed by ChIP assay and real-time PCR using primers 
specifically targeting the putative ATF4 response elements (RE) in the Puma and 
Chop promoters. Data is reported as fold increase over untreated control samples 
for each promoter region (n=5; *p<0.01).   
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3.6.1 ATF3 does not regulate PUMA expression or neuronal 
apoptosis during ER dysfunction 
The above results suggest that an intermediary factor is involved in ATF4-mediated 
Puma induction. Previous studies have suggested a relationship between ATF4 and the 
transcription factors, ATF3 and CHOP (Jiang et al., 2004; Jiang et al., 2007). Therefore, 
we first considered the involvement of ATF3 by confirming its gene expression levels in 
ATF4-null neurons following TM exposure. In agreement with our previous results, in 
Figure 3.9c, that determined ATF3 protein expression was strongly ATF4-dependent up 
to 8h, we found that ATF4-deficiency severely impaired Atf3 mRNA expression 12h 
post-treatment with TM (Fig. 3.14a). We next assessed the contribution of ATF3 in the 
regulation of Puma expression and neuronal cell death during ER-stress. As shown in 
Figure 3.14b, after 8h of TG treatment, cortical neurons lacking ATF3 did not show 
reduced levels of Puma mRNA compared with wild type littermates. Additionally, 
ATF3-deleted neurons showed no observable difference in the degree of ER-stress-
mediated neuronal apoptosis relative to wild types (Fig. 3.14c).  
3.6.2 ATF4-CHOP drives PUMA induction and neuronal apoptosis 
in response to ER-stress 
Since we did detect the enhanced binding of ATF4 to the CHOP promoter in neurons 
during ER-stress (Fig. 3.13b), we hypothesized that ATF4 may regulate Puma induction 
through CHOP. Indeed CHOP protein levels were strongly enhanced in wild type cortical 
neurons following treatment with TG or TM, and dramatically reduced in ATF4-deficient 
neurons, consistent with its activation primarily driven by ATF4 in this paradigm (Fig. 
3.9c and Appendix C Figure 1). Interestingly, CHOP was originally described as a DNA-
damage-sensitive gene in non-neuronal systems (Luethy et al., 1990), however we did not 
detect Chop mRNA or protein expression in cortical neurons exposed to DNA damaging 
agents (Galehdar et al., 2010). We next determined whether CHOP can activate the 
PUMA promoter from the ATF4 responsive region. To do so, we performed ChIP assays 
to determine whether CHOP binds to the PUMA promoter in situ during ER-stress.  As 
shown in Figure 3.15a, CHOP binding to the PUMA promoter increased approximately 
3-fold following treatment with TM or TG, but was not increased by CPT treatment. 
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These results suggest that CHOP can directly regulate the PUMA promoter during ER-
stress, but not in response to DNA damage. Interestingly, we found that the enforced 
expression of CHOP was sufficient to induce apoptosis in wild type neurons but not in 
PUMA
-/-
 neurons suggesting that PUMA is required for CHOP induced cell death (Fig. 
3.15b). Moreover, the targeted knockdown of CHOP was sufficient to significantly 
attenuate ER-stress-induced Puma expression and neuronal apoptosis (Galehdar et al., 
2010). 
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Figure 3.14. ATF3 does not mediate Puma expression or neuronal apoptosis 
during ER-stress. 
A. Total RNA was isolated from ATF4+/+ and ATF4-/- neurons 12h post-treatment 
with 4 µM TM, and mRNA levels of Atf3 were determined by qRT-PCR. 
Expression was normalized to s12 mRNA levels (n=3; ***p<0.001). B. Total 
RNA was isolated from ATF3+/+ and ATF3-/- neurons 8h post-treatment with 3 µM 
TG, and mRNA levels of Puma were determined by qRT-PCR. Expression was 
normalized to s12 mRNA levels (n=3). C. The fraction of apoptotic cells showing 
chromatin condensation and fragmented nuclei relative to healthy cells was 
determined in ATF3+/+ and ATF3-/- cortical neurons (n=3). Representative panels 
of wild type and ATF3-null cortical neurons fixed and stained with Hoechst stain 
(1:1000) 24h post-treatment with 3 µM TG. The red arrow indicates apoptotic 
nuclei, and the green arrow indicates healthy nuclei (400X magnification).  
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Figure 3.15. CHOP activates the Puma promoter and induces neuronal 
apoptosis in a PUMA-dependent manner in response to ER-stress. 
A. Cortical neurons were treated with CPT (10 µM), TU (4 µM) or TG (3 µM) 
and CHOP binding to the Puma promoter was assessed after 12 hours by ChIP 
assay. The level of CHOP binding was quantified by real-time PCR and is 
reported as fold enrichment over untreated controls (n=4; *p<0.05). B. Cortical 
neurons derived from Puma
+/+
 and Puma
-/-
 littermates were nucleofected with 
pGFP and either pcDNA3 (empty vector (EV)) or pcDNA3-CHOP. Neurons were 
Hoechst stained 48 hours post-transfection and the fraction of GFP positive 
neurons exhibiting an apoptotic nuclear morphology was determined (n=3; 
*p<0.05). 
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3.7 Hypoxic stress triggers PUMA expression, caspase-3 
activation, and neuronal apoptosis 
Hypoxic stress plays a key role in modulating neuronal death in the ischemic penumbral 
zone following stroke. Interestingly, cell death in this region is believed to be apoptotic in 
nature, occurring over an extended time frame after the initial insult (Banasiak et al., 
2000; Nakajima et al., 2000). The prolonged aspect of neuronal death in the peri-infarct 
tissue offers an intriguing opportunity for therapeutic intervention. Therefore we 
proposed identifying molecular targets that are essential for delayed neuronal death using 
an in vitro model of hypoxia-induced neuronal apoptosis. Firstly, we compared the 
amount of apoptotic cell death between 7-DIV wild type cortical neuron cultures under 
normoxic conditions versus those exposed to continuous hypoxia (0.5% O2(g)), for 24h, 
using Hoechst nuclear staining. Continuous hypoxia (0.5% O2(g)) induced key hallmarks 
of apoptosis including chromatin condensation and nuclear pyknosis in ~50% of neurons 
(Figure 3.16a). Because hypoxic neuronal death can be antagonized by inhibitors of de 
novo gene synthesis (Halterman et al., 2008), we next determined the time-course 
expression of selected BH3-only genes, Puma, Bim, Hrk and Noxa in response to 
continuous hypoxia. In Figure 3.16b, we show that only Puma mRNA was significantly 
enhanced after 16 and 24h of hypoxic stress. Moreover, we show that protein levels of 
PUMA and cleaved caspase-3 were robustly accumulated 24h post- hypoxia (0.5% O2(g)) 
(Fig. 3.16c).  
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Figure 3.16. Hypoxic stress triggers PUMA expression, caspase-3 activation, 
and neuronal apoptosis. 
A. Representative panels of control (normoxia, N) and hypoxia (0.5% O2(g)) (H) 
wild type cortical neurons fixed and stained with Hoechst stain (1:1000) 24h post-
hypoxia. The fraction of healthy (green arrow) and apoptotic cells (red arrow) 
showing chromatin condensation and fragmented nuclei was determined (400X 
magnification). B. Total RNA was isolated from wild type cortical neurons 8h, 
16h and 24h post-hypoxia, and the mRNA levels of Puma, Noxa, Bim and Hrk 
were determined by qRT-PCR. Expression was normalized to s12 mRNA levels 
and is reported as fold increase relative to normoxic control cells (n=3; #p < 0.05; 
*p < 0.001). C. Wild type cortical neurons were exposed to hypoxic stress, and 
after 24h, protein levels of PUMA, cleaved caspase-3 (cCasp3), and the loading 
control, Actin, were assessed as a whole cell extract by Western blot analysis. 
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3.8 Hypoxic stress triggers caspase-3 activation and 
neuronal apoptosis in a PUMA- and BAX-dependent 
manner 
We and others have shown that PUMA is a critical mediator of neuronal apoptosis 
triggered by pharmacological inducers of oxidative dysfunction and ER-stress (Steckley 
et al., 2007; Bernstein et al., 2011; Galehdar et al., 2010). Interestingly, recent evidence 
supports that continuous hypoxia is capable of eliciting markers of both oxidative- and 
ER-stress (Liu et al., 2008; Halterman et al., 2008). Therefore, we wanted to address 
whether PUMA-deficiency could also confer significant protection against hypoxic 
stress-induced neuronal death. To do this, we subjected PUMA
+/+
 and PUMA
-/-
 cortical 
neurons to either normoxic conditions or continuous hypoxia, for 24h, and assessed 
apoptotic cell death via nuclear staining. In Figure 3.17a, we show that PUMA-null 
neurons were significantly protected (***p < 0.001), relative to wild type littermates. We 
next confirmed by Western blotting that PUMA-depleted neurons did not show any 
accumulation of cleaved caspase-3 in response to hypoxic stress, relative to the 
pronounced levels observed in PUMA
+/+
 (Fig. 3.17b).  
The pro-death function of PUMA is generally understood to be a key catalyst 
towards the activation of BAX, coupled with the subsequent permeabilization of 
mitochondria. Because BAX plays a crucial role in this process, we aimed to determine 
whether BAX-depletion would abrogate hypoxia-induced neuronal apoptosis to a similar 
extent. We determined by Western blotting in Figure 3.18a that BAX-deficiency 
effectively mitigated the cleavage of caspase-3, relative to the enriched amount present in 
BAX
+/-
 neurons. We also determined, that the amount of chromatin condensation and 
pyknotic nuclei is significantly reduced (***p < 0.001) in BAX
-/-
 relative to BAX
+/-
 
littermates (Fig. 3.18b). 
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Figure 3.17. Hypoxic stess triggers caspase-3 activation and neuronal 
apoptosis in a PUMA-dependent manner. 
A. PUMA+/+ and PUMA-/- cortical neurons were exposed to either normoxia (N) or 
hypoxia (0.5% O2(g)) (H) conditions, and after 24h, protein levels of PUMA, 
cleaved caspase-3 (cCasp3), and the loading control, Actin, were assessed as a 
whole cell extract by Western blot analysis. B. Representative panels of PUMA+/+ 
and PUMA-/- cortical neurons fixed and stained with Hoechst stain (1:1000) 24h 
post-hypoxia. The fraction of apoptotic cells (red arrow) showing chromatin 
condensation and fragmented nuclei relative to healthy cells (green arrow) was 
determined (n=3; ***p<0.001) (400X magnification).  
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Figure 3.18. BAX is critical during hypoxia-induced caspase-3 activation and 
neuronal apoptosis. 
A. BAX+/- and BAX-/- cortical neurons were exposed to either normoxia (N) or 
hypoxia (0.5% O2(g)) (H) conditions, and after 24h, protein levels of BAX, 
cleaved caspase-3 (cCasp3), and the loading control, Actin, were assessed as a 
whole cell extract by Western blot analysis. B. Representative panels of BAX+/- 
and BAX-/- cortical neurons fixed and stained with Hoechst stain (1:1000) 24h 
post-hypoxia. The fraction of apoptotic cells (red arrow) showing chromatin 
condensation and fragmented nuclei relative to healthy cells (green arrow) was 
determined (n=3; ***p<0.001) (400X magnification). 
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3.9 Hypoxia-induced PUMA expression is p53-independent 
PUMA is a critical downstream effecter of p53 in response to DNA damaging agents and 
some oxidative stressors however, cytokine deprivation, serum withdrawal, ER-stress and 
arsenite toxicity have been reported to activate p53-independent pathways (Nakano and 
Vousden, 2001; Yu et al., 2001; Han et al., 2001; Jeffers et al., 2003; Villunger et al., 
2003; Steckley et al., 2007; Bernstein et al., 2011; Fricker et al., 2010; Galehdar et al., 
2010). In order to determine if p53 plays a role in hypoxia-induced PUMA expression, 
we examined the time-course accumulation of p53, PUMA and cleaved caspase-3 protein 
in wild type neuronal lysates. In Figure 3.19a, we show that p53 protein is not enriched in 
response to continuous hypoxia (0.5% O2(g)), as compared to the robust stabilization 
induced by the DNA damaging agent, camptothecin (CPT). Interestingly, we observed 
increases in both PUMA and activated caspase-3 protein levels, suggesting a p53-
independent mechanism. Next we considered the impact of p53-deletion on Puma 
expression triggered by hypoxic stress. When p53
+/- 
and p53
-/-
 cortical neurons were 
exposed to continuous hypoxia for 8, 16 and 24h, we observed no significant difference 
in Puma expression between genotypes (Fig. 3.19b). Moreover, the degree of apoptotic 
neuronal death between p53
+/- 
and p53
-/- 
was almost identical (Fig. 3.19c).  
Since our model of hypoxia-induced neuronal apoptosis indicated the 
involvement of a p53-independent pathway, we next assessed the expression of the pro-
death factor, ATF4. Consistent with this, recent evidence suggests that hypoxic stress 
increases reactive oxygen species production leading to the induction of the ISR, an arm 
of the unfolded protein response geared towards the adaptation to ER-stress (Liu et al., 
2008). Indeed, ATF4 is known to modulate p53-independent apoptosis in a variety of 
stress paradigms (Galehdar et al., 2010; Qing et al., 2012). Firstly, we analyzed Atf4 
mRNA levels in wild type neuronal cultures following 8, 16 and 24h post-hypoxia (Fig. 
3.20a). Although we did not detect any significant changes at the gene expression level 
we did find that ATF4 protein and P-eIF2α were enhanced after 20h of continuous 
hypoxic stress (Fig. 3.20b). Consistent with this, Blais and colleagues (2004) reported a 
similar trend favouring a translational induction of ATF4 over a transcriptional response. 
Lastly, we aimed to investigate the p53-independent pathway by establishing a link 
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between ATF4-PUMA in p53-depleted neurons. To do this, we determined PUMA, 
cleaved caspase-3, p53 and ATF4 protein levels in p53
+/- 
and p53
-/-
 cortical cultures 
exposed to hypoxic stress over 24h. In agreement with our previous data, we did not 
observe p53 stabilization after hypoxic stress however, we did detect ATF4 protein 
expression, which closely mirrored the up-regulation of PUMA and activated caspase-3 
(Fig. 3.20c).  
3.10 Hypoxia induces PUMA expression, caspase-3 
activation, and neuronal apoptosis in an ATF4-
dependent manner 
ATF4 has recently been implicated as a critical mediator of neuronal death triggered by 
ischemia, amyloid-beta toxicity and ER dysfunction (Lange et al., 2008; Baleriola et al., 
2014; Galehdar et al., 2010). Since ATF4 is known to directly regulate Puma expression 
independently of p53 during amino acid deprivation (Qing et al., 2012), we aimed to 
show whether ATF4-deficiency would reduce hypoxia-induced Puma expression. Firstly, 
we analyzed Puma mRNA in ATF4
+/o
 and ATF4
-/-
 cortical cultures over 8 and 16h of 
continuous hypoxia and found a significant reduction after 16h (*p < 0.05) (Fig. 3.21a). 
Similarly, we observed that ATF4-null neurons displayed significantly less neuronal 
apoptosis than their ATF4
+/o 
counterparts 24h post-hypoxia (***p < 0.001) (Fig. 3.21b). 
Finally, we found that ATF4 status was critical to caspase-3 activation following 24h of 
hypoxic stress, as evidenced in ATF4-depleted neurons that showed minimal cleaved 
caspase-3, relative to wild type (Fig. 3.21c). 
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Figure 3.19. Hypoxia-induced PUMA expression is p53-independent. 
A. Wild type cortical neurons were exposed to either normoxic conditions for 0h 
or hypoxic stress, and after 2, 4, 8, 16 and 24h, protein levels of p53, PUMA, 
cleaved caspase-3 (cCasp3), and the loading control, Actin, were assessed as a 
whole cell extract by Western blot analysis. A positive control lane was included 
using wild type cortical neuron lysates treated with the DNA damaging agent, 
Camptothecin (CPT), to estimate p53 levels. B. Total RNA was isolated from 
p53+/- and p53-/- cortical neurons 8h, 16h and 24h post-hypoxia, and the mRNA 
level of Puma was determined by qRT-PCR. Expression was normalized to s12 
mRNA levels and is reported as fold increase relative to normoxic control cells 
(n=5). C. Representative panels of p53+/- and p53-/- cortical neurons fixed and 
stained with Hoechst stain (1:1000) 24h post-hypoxia. The fraction of apoptotic 
cells (red arrow) showing chromatin condensation and fragmented nuclei relative 
to healthy cells (green arrow) was determined (n=3) (400X magnification).  
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Figure 3.20. Hypoxia induces the enrichment of ATF4, PUMA and cleaved 
caspase-3 in p53-deficient neurons. 
A. Total RNA was isolated from wild type cortical neurons 8h, 16h and 24h post-
hypoxia (0.5% O2(g)), and the mRNA level of Atf4 was determined by qRT-PCR. 
Expression was normalized to s12 mRNA levels and is reported as fold increase 
relative to normoxic control cells (n=3). B. Wild type cortical neurons were 
exposed to either normoxic (N) conditions or hypoxic stress (H), and after 20h, 
protein levels of ATF4, P-eIF2α were assessed as a whole cell extract by Western 
blot analysis. The membrane was then stripped and re-probed for the loading 
control, total eIF2α. A positive control lane was included using a wild type 
cortical neuron lysate treated with the ER-stress agent, Thapsigargin (TG), for 
24h, to stimulate an ER-stress response. C. p53+/- and p53-/- cortical neurons were 
exposed to either normoxic or hypoxic conditions, and after 24h, protein levels of 
p53, ATF4, PUMA, cleaved caspase-3 (cCasp3), and the loading control, total 
eIF2α, were assessed as a whole cell extract by Western blot analysis. CPT was 
included as a positive control, as described above. 
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Figure 3.21. Hypoxia induces PUMA expression, caspase-3 activation, and 
neuronal apoptosis in an ATF4-dependent manner.  
A. Total RNA was isolated from ATF4+/o and ATF4-/- cortical neurons 8h, 16h 
post-hypoxia, and the mRNA level of Puma was determined by qRT-PCR. 
Expression was normalized to s12 mRNA levels and is reported as fold increase 
relative to normoxic control cells (n≥3; *p < 0.05). B. Representative panels of 
ATF4+/+/ATF+/- (ATF4+/o) and ATF4-/- cortical neurons fixed and stained with 
Hoechst stain (1:1000) 24h post-hypoxia. The fraction of apoptotic cells (red 
arrow) showing chromatin condensation and fragmented nuclei relative to healthy 
cells (green arrow) was determined (n≥3; ***p < 0.001) (400X magnification). C. 
ATF4+/+ and ATF4-/- cortical neurons were exposed to either normoxic conditions 
(N) or hypoxic stress (H), and after 24h, protein levels of ATF4, cleaved caspase-
3 (cCasp3), and the loading control, Actin, were assessed as a whole cell extract 
by Western blot analysis. 
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Chapter 4 
4 Summary and Discussion 
The goal of this work was to identify candidate genes that play a critical role in 
modulating neuronal death in response to stress pathways intimately associated with 
neurodegenerative pathologies. Ideally, the long term goal would be the implementation 
of targeted therapeutics designed to inhibit the expression of pro-death mediators to 
preserve brain function and structural integrity. To this end we have identified the 
transcription factors, ATF4 and CHOP, and the pro-death genes, PUMA and BAX, as 
key players associated with neuronal apoptosis driven by ER-stress, oxidative 
dysfunction and delayed neuronal death triggered by hypoxic stress (Figure 4.1).  
4.1 Summary of ER-stress-mediated neuronal apoptosis 
Indeed ER-stress has been linked with the disease course of AD, PD and ALS, and acute 
neuronal death induced by cerebral ischemia (Hoozemans et al., 2005; Hoozemans et al., 
2007; Atkin et al., 2008; Morimoto et al., 2007). The manifestation of ER dysfunction is 
carried out through the concerted effort of the UPR to restore homeostatic balance to the 
ER lumen. Protein translation is arrested and ER chaperones are redistributed to 
coordinate the systematic degradation of misfolded aggregates thereby alleviating the 
toxic protein load. If the intensity of the stress proves too great and cannot be resolved, 
the gradual accumulation of pro-death effectors drives the cell to commit suicide (Hetz, 
2012). The relative importance and contribution of ER-stress related proteins to neuronal 
apoptosis is not completely resolved. Under pathological conditions, the UPR is 
paradoxically associated with facilitating recovery after spinal cord injury (Valenzuela et 
al., 2013), and enabling disease course via increased BACE1 expression in AD 
(O’Connor et al., 2008).  
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Figure 4.1. Summary of findings. 
From this work we have shown that ER-stress induced the sequential activation of ATF4 
followed by the stabilization of CHOP, which was required to directly induce PUMA 
expression and neuronal apoptosis. Second, we demonstrated that the oxidative stressor, 
arsenite, selectively enhanced UPR factors, of which ATF4 played a dominant role in the 
modulation of PUMA, caspase-3 activity and neuronal death. In our final aim, we 
employed a physiological model of oxygen deprivation and found that ATF4 played an 
essential role in regulating PUMA expression and caspase-3 activity. Remarkably, we 
and others (Fricker et al., 2010) have demonstrated that p53 does not regulate neuronal 
apoptosis under each of our experimental parameters. 
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Our results have shown that ATF4, an essential modulator of the ISR, plays a critical role 
in the regulation of neuronal apoptosis in response to ER-stress. We have also 
demonstrated that ATF4 regulates Puma mRNA levels induced by ER-stress, whereas 
p53 is dispensable in this context. Conversely, ATF4 does not dictate Puma expression or 
neuronal apoptosis triggered by DNA damage, which we showed to be strongly p53-
dependent (Galehdar et al., 2010). We further elaborated that ER dysfunction led to the 
sequential enhancement of ATF4 and CHOP, of which the latter was directly responsible 
for the induction of PUMA and neuronal cell death. 
In non-neuronal systems, ER-stress was shown to promote apoptosis in a partially p53- 
and NOXA-dependent manner (Li et al., 2006). Conversely, we found that in post-mitotic 
neurons, p53 was not required for this process, which may be attributable to ER-stress-
mediated degradation of p53 (Galehdar et al., 2010; Qu et al., 2004). Similarly, ATF4 
does not modulate DNA damage-induced neuronal apoptosis rather this may be due to an 
accumulation of the LIP isoform of C/EBPβ, a known transcriptional repressor of ATF4, 
which can be regulated by genotoxic stress (Galehdar et al., 2010; Dey et al., 2012). 
Importantly, we considered the contribution of another BH3-only gene, BIM, as BIM was 
induced at the mRNA and protein level following ER-stress. Although PUMA-deletion 
rescued neurons from ER-stress toxicity, this phenomenon was not recapitulated in BIM-
null neurons, suggesting that PUMA plays a dominant role in the regulation of stress-
induced neuronal death (Steckley et al., 2007; Galehdar et al., 2010).  
We next determined whether ATF4 mediated PUMA expression via a direct 
transcriptional mechanism by performing a chromatin immunoprecipitation. Our results 
indicated that ATF4 did not directly induce PUMA but rather, we detected an enrichment 
of the ATF4-target gene, CHOP, at the PUMA promoter. CHOP has also been shown to 
modulate BIM expression in non-neuronal cells (Puthalakath et al., 2007). Interestingly, 
ATF4 was recently ascribed as a direct regulator of PUMA in response to nutrient 
deprivation (Qing et al., 2012). Although ATF4-deletion and CHOP knockdown afforded 
significant protection from ER-stress-mediated neuronal apoptosis, the survival benefit 
was incomplete. This suggests the involvement of alternative mechanisms possibly 
attributable to other UPR factors like, XBP1 or ATF6. Interestingly, the enforced 
expression of ATF6 can induce CHOP however XBP1 does not appear to influence 
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CHOP levels (Yoshida et al., 2000; Lee et al., 2003). Moreover, ATF6α-deficient mice 
are sensitized to ER-stress in vivo, and the endogenous knockdown of XBP1 within the 
midbrain enhances dopaminergic neuronal death (Wu et al., 2007; Valdés et al., 2014). 
Another potential candidate is the transcriptional regulator, FOXO3a, which has been 
shown to activate PUMA expression in neuronal and non-neuronal systems (Zou et al., 
2009; You et al., 2006). FOXO3a was recently demonstrated to regulate PUMA 
independently of p53 in response Aβ treatment, a stimulus capable of inducing ER-stress 
(Yoon et al., 2012; Akhter et al., 2014; Feng et al., 2015). 
4.2 Summary of arsenite-mediated neuronal apoptosis 
Oxidative stress occurs when the amount of ROS produced through endogenous or 
hazardous mechanisms cannot be efficiently detoxified by our intrinsic antioxidants, 
thereby making cellular biomolecules increasingly vulnerable to the abundance of toxic 
modifiers. Although a substantial body of work has linked oxidative dysfunction with the 
etiology of several neurodegenerative illnesses, the mechanisms regulating cell death are 
poorly understood. 
Our second aim elaborated the signaling pathway regulating PUMA expression and 
neuronal apoptosis induced by the oxidative stressor, sodium arsenite, a stimulus capable 
of driving p53-independent neuronal death (Fricker et al., 2010). Arsenite toxicity is 
thought to arise from the generation of several free radicals and non-radicals such as, NO, 
ONOO-, H2O2 and hydroxyl (Chattopadhyay et al., 2002; Guidarelli et al., 2005; Chen et 
al., 1998; Garcia-Chavez et al., 2003). Chronic exposure to arsenite can also further 
reduce the brain’s limited antioxidant defenses by lowering SOD and GSH levels 
(Garcia-Chavez et al., 2003; Namgung and Xia, 2001).  
Importantly, components of the UPR can be induced by oxidative dysfunction, 
independently of ER-stress and PERK activation. For instance, ATF4 requires both 
stress-induced transcriptional control and favorable translational conditions via P-eIF2α 
to accumulate to appreciable levels. Interestingly, both ER-stress and UV irradiation can 
induce P-eIF2α, however only ER-stress robustly enhanced ATF4 levels while UV 
irradiation inhibited its transcription (Dey et al., 2010; Dey et al., 2012). Since we and 
others have demonstrated that ATF4 plays a critical role in regulating neuronal apoptosis, 
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it is imperative to define what other ER-stress-independent pathways can accumulate 
ATF4 (Lange et al., 2008; Galehdar et al., 2010, Armstrong et al., 2010).  
The interpretation of cellular stresses by eIF2α kinases, heme-regulated inhibitor (HRI), 
protein kinase RNA-activated (PKR), PKR-like ER kinase (PERK), and general control 
nonderepressible 2  (GCN2), is termed, the Integrated Stress Response (ISR), an adaptive 
pathway regulating antioxidant, chaperone and apoptotic gene expression, largely 
through the activity of ATF4. Although our data supports the pronounced activation of 
notable transcriptional regulators of the ISR like, ATF3, ATF4 and CHOP, we have not 
identified the putative kinase that generates P-eIF2α, a condition that paradoxically 
favors the translation of unique mRNAs. Several reports have suggested that GCN2 is 
abundantly expressed in the brain and may influence ATF4 levels, and modulate P-eIF2α 
in response to oxidative stress (Sood et al., 1998; Costa-Mattioli et al., 2005; Zhan et al., 
2004; Roffé et al., 2013). However, to our knowledge, there is no specific inhibitor of 
GCN2 currently available.  
Other oxidative stressors such as Parkinsonian mimetics, 6-OHDA and MPP+, are known 
to induce ER-stress and the UPR. However, in this scenario the UPR is thought to play a 
pro-survival role in response to 6-OHDA as evidenced by the enhanced degree of 
apoptosis observed in PERK
-/-
 neurons relative to wild type (Ryu et al., 2002). Moreover, 
MPP+ and 6-OHDA have been shown to trigger neuronal apoptosis in a p53-dependent 
manner, whereas p53 is dispensable for arsenite-mediated neuronal apoptosis (Perier et 
al., 2007; Bernstein et al., 2011; Fricker et al., 2010).  
Although there was no evidence of ER-stress, arsenite activated selected components of 
the UPR to promote the induction of PUMA and neuronal apoptosis. Specifically, 
downstream effectors of the PERK pathway, ATF3, ATF4 and CHOP were robustly 
expressed by arsenite in a PERK-independent manner. Using gene-specific knockout 
mice, we analyzed the contribution of ATF3, ATF4 and CHOP in the regulation of 
arsenite-mediated PUMA expression and neuronal survival. We determined that only the 
deletion of ATF4 was sufficient to significantly attenuate Puma mRNA, caspase-3 
activation and neuronal apoptosis, in response to arsenite stress. In contrast to our initial 
finding, where we identified CHOP as a key regulator of ER-stress-induced PUMA 
101 
 
expression and neuronal apoptosis, we found that in the context of arsenite toxicity, 
CHOP-deletion did not mitigate Puma levels or neuronal apoptosis. Other distinctions 
between ER- and oxidative stress signaling involved the differential regulation of ATF3. 
In the ER-stress paradigm, the initial up-regulation of ATF4 was followed by CHOP and 
then ATF3. Conversely, arsenite exposure induced ATF4, and then incurred the 
expression of ATF3 and CHOP simultaneously. We also indicated that ROS generated by 
arsenite toxicity played a crucial role in stabilizing ATF4 protein, as this effect was 
abrogated by the antioxidant, NAC. However, pretreatment with NAC did not reduce ER-
stress-mediated ATF4 expression.  
Another important distinction in our findings included the observation that neurons 
lacking ATF3- or CHOP did not show significant protection from arsenite stress, whereas 
MEFs harboring deletions for ATF3 or CHOP exhibited a strong reduction in apoptosis 
triggered by arsenite toxicity (Jiang et al., 2007). Moreover, ATF4-depleted MEFs were 
sensitized to apoptotic cell death (Jiang et al., 2007), while our results from ATF4-/- 
neurons were consistent with previous data that showed the opposite phenotype (Lange et 
al., 2008). One key difference from our work relates to the unequal contribution of CHOP 
towards the regulation of PUMA in the context of ER dysfunction and its expendable role 
in modulating PUMA expression during arsenite stress. This potentially reflects a 
dichotomous posttranslational regulation of CHOP and ATF4 by the ubiquitous kinase, 
casein kinase-2 (CK2). Indeed, it has been reported that arsenite stress can stimulate CK2 
leading to both an enhancement and a reduction in the transcriptional activities of ATF4 
and CHOP, respectively (Sayed et al., 2000; Ubeda and Habener, 2003; Ampofo et al., 
2013).  
We also proposed that the hierarchical regulation between the transcription factors ATF3, 
ATF4 and CHOP was distinct between stress paradigms. During ER-stress, we elaborated 
the sequential activation of ATF4, which induced CHOP followed by ATF3, whereas 
during arsenite treatment, ATF3 and CHOP were similarly expressed after ATF4 
stabilization. Our results are consistent with previous reports that also demonstrated a 
stepwise pattern of CHOP preceding ATF3 expression, following ER-stress (Zinszner et 
al., 1998; Jiang et al., 2004). However during arsenite exposure, ATF4-null neurons 
showed no residual induction of ATF3 or CHOP, whereas in MEFs, other transcription 
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factors compensate for the absence of ATF4 to modestly increase their expression (Jiang 
et al., 2007). Moreover, intervention with the antioxidant, NAC, attenuated ATF4 levels 
induced by arsenite, a finding that is supported in non-neuronal cells (Roybal et al., 2005; 
Jiang et al., 2007). Interestingly, Malhotra and others (2008) showed that the lipid-soluble 
antioxidant, butylated hydroxyanisole, reduced ER-stress by suppressing multiple UPR-
related transcripts. In contrast to our results, NAC did not mitigate ATF4 protein induced 
by ER dysfunction. Although we have associated ATF4 with a pro-death function, it was 
recently reported that ATF4 regulates both ATF6 expression and processing, indicating a 
disparate and potentially protective role, as ATF6α-null mice are sensitized to oxidative 
stress in vitro and in vivo (Teske et al., 2011; Egawa et al., 2011; Hashida et al., 2012).  
Since we have not associated a direct transcriptional function to ATF4 driving PUMA 
expression, we have considered an alternative mechanism involving an intermediate, 
GADD45α. Indeed recent reports have suggested that GADD45α knockdown 
significantly attenuated oxidative stress- and glutamate-induced apoptosis (Gao et al., 
2013; Choi et al., 2011). Moreover, GADD45α is an ATF4-target gene that can be up-
regulated independently of p53 (Jiang et al., 2007; Gao et al., 2013). Interestingly, 
GADD45α expression is substantially increased in AD post-mortem brain tissue relative 
to age-matched control brains (Torp et al., 1998). Future studies would include a targeted 
knockdown approach using a lentiviral vector expression system. 
4.3 Summary of hypoxia-induced neuronal apoptosis 
In the current study, we investigated the molecular events leading to neuronal apoptosis 
during continuous hypoxic stress. We propose that hypoxic neuronal injury triggers the 
expression of the BH3-protein, PUMA, in an ATF4-dependent and p53-independent 
manner. Although we and others have reported that hypoxia and ischemic neuronal injury 
can induce PUMA, some recent data suggested that PUMA is not expressed following 
oxygen-glucose deprivation (OGD) in cortical cultures (Halterman et al., 2008; Niizuma 
et al., 2009; Pfeiffer et al., 2014). Rather, OGD induced the BH3 gene, Bmf, and Bmf-
depletion was sufficient to significantly reduce infarct size after transient middle cerebral 
artery occlusion (tMCAO) (Pfeiffer et al., 2014). Similarly, BID
-/-
 mice were able to 
resist significant neuronal loss following tMCAO (Plesnila et al., 2001). These data 
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confirm that apoptosis plays a critical role in neuronal death after ischemic insults. Thus 
it would be important to identify whether our in vitro observations in PUMA-null mice 
can be translated to in vivo models. Functionally, BH3-only family members are known 
to facilitate apoptosis either through the direct or indirect activation of BAX (Kim et al., 
2006; Willis et al., 2007; Du et al., 2011). Because BAX serves as a key gateway to the 
initiation of mitochondrial permeabilization and caspase activation, we tested the impact 
of BAX deletion on neuronal survival after hypoxic stress. Similar to our data from 
PUMA
-/-
 neurons, apoptosis was thoroughly compromised in cortical cultures lacking 
BAX. Consistent with this, neonatal BAX-deficient mice that were subjected to hypoxic-
ischemic (HI) brain injury showed reduced caspase activation and tissue damage relative 
to wild type (Gibson et al., 2001). Interestingly, the pharmacological inhibition of BAX 
activation after HI has been demonstrated with promising results extending towards 
functional recovery (Wang et al., 2010b). This was an important finding because of the 
profound and persistent behavioral changes that can surface as collateral damage after 
stroke.  
In order to investigate BH3 expression, we elected to survey two known transcriptional 
activators of PUMA, p53 and ATF4, in a model of hypoxia-induced neuronal apoptosis. 
Initially we analyzed whether p53 levels could be stabilized over a time-course of 
hypoxic stress. Strikingly, we found that not only was p53 largely absent over that period 
but there was a substantial enrichment of PUMA and activated caspase-3. The lack of 
p53 accumulation could be due to the oxygen concentration employed in our model. 
Specifically, we used 0.5% O2(g) whereas p53 levels are known to be stabilized at 0.2% 
but not at 2%, indicating a highly specific regulatory mechanism (Hammond et al., 2002). 
We further validated the contribution of p53 using cortical neuronal cultures devoid of 
p53 and analyzed Puma mRNA levels after hypoxia. Our data suggest that p53 does not 
regulate PUMA transcription in this context. Similarly we did not observe any significant 
reduction in neuronal apoptosis between p53 genotypes.  
We next considered if ATF4, a key player in the ER-stress response, could be modulating 
PUMA levels in the absence of p53 involvement. As supported by Blais and others 
(2004), we also showed that hypoxia preferentially stabilizes ATF4 post-translationally. 
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Moreover, Halterman and colleagues (2008) demonstrated that the bZIP transcriptional 
regulator, C/EBPβ, dissipated over the course of hypoxic stress and that decrease 
correlated with an enhancement of ATF4 and the apoptotic response. This distinction is 
supported by the notion that C/EBPβ functions as a repressor of ATF4 expression (Dey et 
al., 2012). Another potential mechanism of ATF4 stabilization involves the oxygen 
sensor, prolyl-4-hydroxylase domain 3 (PHD3). Under normoxic conditions, PHD3 
suppresses ATF4 levels via proteasomal degradation however, during conditions of 
reduced oxygen availability, PHD3 function decreases and ATF4 becomes enriched. This 
was further elaborated when ATF4 accumulated during normoxia, after PHD3 
knockdown (Köditz et al., 2007).  
Our data support that hypoxia stimulates the phosphorylation of eIF2α, which leads to a 
refined increase in ATF4 protein synthesis. The process of eIF2α modification by cellular 
perturbations is termed the Integrated Stress Response (ISR). It is generally understood 
that hypoxia triggers the ISR via the ER membrane kinase, PERK, to phosphorylate 
eIF2α leading to the selective induction of ATF4, as evidenced from PERK-depleted cells 
(Blais et al., 2004). We then demonstrated that ATF4 protein was enhanced in both p53-
heterozygous and -null neurons, with the concurrent expression of PUMA and cleaved 
caspase-3. Moreover we showed that ATF4-deficiency lead to significantly reduced 
Puma levels and neuronal apoptosis after continuous hypoxia. Conversely, Bi and others 
(2005) reported that impairments throughout the ISR lead to the consistent 
hyperactivation of caspase-3 in non-neuronal cells. The consensus on whether ATF4 is 
pro-survival or pro-death is controversial and appears to be both context and cell type 
specific. For instance, in non-neuronal cells hypoxia can trigger the production of ROS, a 
potent stimulus that can lead to enhanced levels of apoptosis in ATF4-deficient MEFs 
(Liu et al., 2008; Jiang et al., 2007). Moreover, ATF4-/- MEFs require supplementation 
with reducing agents to lower the endogenous levels of oxidative stress (Harding et al., 
2003).  Conversely, neurons lacking ATF4 have been shown to resist cell death triggered 
by ER-stress, amyloid beta toxicity, ischemic injury, and show increased survivability in 
ALS model mice (Galehdar et al., 2010; Baleriola et al., 2014; Lange et al., 2008; Matus 
et al., 2013). 
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Although we have implicated ATF4 as a key component regulating PUMA expression in 
response to hypoxic stress, the reduction in Puma mRNA observed in ATF4-null neurons 
appears to be incomplete. Moreover we cannot discount that other BH3-only members or 
unrelated pro-death modulators might be involved since the protection afforded by the 
deletion of ATF4 is not absolute. It is possible that E2F1 could impact PUMA expression 
and neuronal apoptosis during hypoxia, as E2F1-/- mice showed reduced infarct sizes 
following a cerebral ischemic insult (MacManus et al., 2003). Moreover, E2F1 has been 
shown to directly associate with the PUMA promoter, and the enforced expression of 
E2F1 is sufficient to mediate neuronal apoptosis (Hou et al., 2000; Hershko and 
Ginsberg, 2004). Other BH3-only genes that could be playing a compensatory role in this 
paradigm are, Hrk, Bim, Bid, Bmf and Bnip3 (Pike et al., 2012; Plesnila et al., 2001; 
Kuan et al., 2003; Li et al., 2013; Pfeiffer et al., 2014). Interestingly, ATF4 can directly 
induce Hrk expression during severe hypoxia (Pike et al., 2012). 
In summary we propose that ATF4 plays a crucial role in the regulation of delayed 
neuronal death during hypoxic stress in vitro. In our model, ATF4 contributes 
significantly in the regulation of pro-apoptotic gene, PUMA, a known facilitator of BAX 
activation, mitochondrial permeabilization and caspase-3 activation. A growing body of 
evidence from knockout mice of the Bcl-2 family have suggested that apoptosis plays a 
considerable role in the modulation of neuronal loss after ischemia. Moreover, ATF4 is 
known to directly modulate PUMA expression and ATF4-null mice displayed reduced 
infarct volumes after tMCAO (Lange et al., 2008, Qing et al., 2012). Therefore the 
pharmacological inhibition of ATF4 could prove a valuable therapeutic target to mitigate 
delayed neuronal death and preserve functional viability after stroke. 
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4.4 A potential mechanism linking ER-stress and oxidative 
dysfunction with neurodegenerative disease 
progression 
The deleterious contribution of environmental stressors to neurological impairments is 
well-studied (Betarbet et al., 2000; Sherer et al., 2002; Giasson et al., 2000; Lin et al., 
2007). For instance, the pesticide, rotenone and the contaminant, arsenite are known to 
generate oxidative stress, and contribute to the toxic gain-of-function of αS into a more 
aggressively aggregating species (Sherer et al., 2002; Lin et al., 2007; Giasson et al., 
2000). The cellular hub for the generation of oxidative stress is the mitochondrion, and 
deficits in electron transport through the ETS are strongly linked to excessive ROS 
production, and the disease course of AD, PD and ALS (Lin and Beal, 2006). It was 
recently demonstrated that mitochondrial-derived ROS can enhance the amyloidogenic 
processing of APP, yielding the neurotoxic oligomer, Aβ (Leuner et al., 2012). Similarly, 
the enhanced expression of αS can increase ROS production, and nitrosative stress arising 
from ONOO- can deactivate SOD1 function, increasing cellular susceptibility to ROS 
(Aoyama et al., 2000; Hsu et al., 2000). Indeed both aggregated αS, Aβ and misfolded 
SOD1 are known to localize in the ER and associate with the chaperone, BiP, which is 
thought to sensitize cells to ER-stress (Kikuchi et al., 2006; Colla et al., 2012; Soejima et 
al., 2013). Interestingly, the αS-BiP interaction was detected in presymptomatic PD-
model mice (Colla et al., 2012). Consistent with this, UPR sensors and BiP were shown 
to be activated in ALS- and AD-model mice prior to disease onset (Atkin et al., 2008; 
Soejima et al., 2013).  
Taken together, current evidence suggests that excessive ROS can profoundly modify 
wild type proteins into toxic disease enablers and this may have to do with a detrimental 
association with the ER chaperone, BiP. By removing BiP from the luminal domains of 
ER-stress sensors, the UPR is inappropriately activated for a sustained duration. This 
could explain why the UPR has been observed early on in young AD-, PD- and ALS-
model mice before and during symptom onset, and remains induced until death, as 
evidenced in human post-mortem tissues (Colla et al., 2012; Soejima et al., 2013; 
Hoozemans et al., 2005; Hoozemans et al., 2007; Atkin et al., 2008) (Figure 4.2). 
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Figure 4.2. ER and oxidative dysfunction can potentiate neurodegenerative disease. 
Mitochondria are central to the generation of ATP via oxidative phosphorylation. 
However, ROS escaping from the ETS can detrimentally alter cellular macromolecules. 
Alpha synuclein (αS) and superoxide dismutase-1 (SOD1) can acquire toxic attributes 
through ROS-mediated alterations. Moreover, amyloid beta (Aβ) generation can be 
induced by ROS, which instigates a vicious cycle furthering mitochondrial impairments. 
The newly accumulated toxic proteins can also localize within the ER where they may 
interact with the ER chaperone, BiP. It is possible that this interaction sensitizes the cell 
to a persistent induction of the UPR, as markers of the ER-stress response have been 
detected throughout the life of animal and human neurodegenerative disease-affected 
tissues. 
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The importance of BiP in neurons was demonstrated in vivo using a conditional BiP 
knockout in the Purkinje cells (PC) of the cerebellum. PC lacking BiP showed enhanced 
CHOP expression, caspase activation and a significant increase in neuronal apoptosis, 
relative to wild type (Wang et al., 2010a). Finally, pretreatment with an exogenous BiP 
inducer significantly attenuated CHOP levels and infarct size, compared with untreated 
mice subjected to cerebral ischemia (Kudo et al., 2008). 
4.5 The role of ATF4 in chronic neurodegenerative disease 
Given the recent evidence suggesting that the UPR is profoundly activated before 
disease-related symptoms arose, the next consideration was to analyze downstream 
effectors of the UPR to evaluate their importance in the determination of cell fate. Within 
the context of ALS, this was achieved by crossing mice expressing mutant SOD1 with 
mice carrying a targeted deletion for the pro-death gene, ATF4, which resulted in their 
increased survival, relative to wild type littermates (Matus et al., 2013). The pro-
apoptotic function of ATF4 is believed to be executed either through the intermediate 
expression of CHOP, followed by the induction of the BH3-only genes, BIM and PUMA, 
or via the direct transcription of PUMA (Galehdar et al., 2010; Qing et al., 2012; Matus et 
al., 2013; Puthalakath et al., 2007). Consistent with this, PUMA, BIM and CHOP were 
found to be robustly expressed in SOD1G93A mice prior to the development of the ALS 
phenotype, and motorneurons derived from SOD1G93A-PUMA-/- mice showed enhanced 
survival (Kieran et al., 2007). This protective benefit was also observed in BAX-
depleted-SOD1G93A animals (Gould et al., 2006). Interestingly, BAX oligomerization was 
detected in autopsied ALS tissue whereas control cases did not display signs of BAX 
activation (Martin, 1999).  
The prolonged induction of the UPR and ATF4 is a prominent feature in AD, as observed 
in animal models of disease and post-mortem AD brain tissue (Ma et al., 2013; O’Connor 
et al., 2008; Lewerenz and Maher, 2009; Yoon et al., 2012; Hoozemans et al., 2005). 
Moreover, exogenous treatment with Aβ can induce ER- and oxidative stress in neuronal 
cells, and ATF4 knockdown rescued selected neuronal populations from Aβ-mediated 
toxicity in vivo (Leuner et al., 2012; Yoon et al., 2012; Baleriola et al., 2014). In 
agreement with our results, ATF4-depletion also attenuated neuronal apoptosis induced 
by ER and oxidative dysfunction, and this is thought to be mediated through a PUMA 
109 
 
and BAX-dependent pathway (Galehdar et al., 2010). Indeed Aβ stress has been shown to 
drive neuronal apoptosis through an intrinsic mitochondrial route, as evidenced in 
PUMA- and BAX-deficient neurons, and also through caspase activation in vivo (Feng et 
al., 2014; Akhter et al., 2014; Kudo et al., 2012; Xie et al., 2013). 
In contrast to the pro-death function of ATF4 in AD, ALS and ischemic neuronal injury, 
its role in PD appears to favor survival. For example, it was recently shown that ATF4 
knockdown sensitized neuronal cells to PD-inducing neurotoxins due to the reduction of 
Parkin (Sun et al., 2013). Interestingly and in the context of experimental PD, p53 
appears to play a critical role in the regulation of neuronal death in vitro and in vivo 
(Perier et al., 2007; Bernstein et al., 2011; Bernstein and O’Malley et al., 2013). 
Conversely, ATF4 directs Parkin expression to reverse MPP+-induced neurotoxicity, 
suggesting that ATF4 observed in the PD brain plays a preservative role (Bouman et al., 
2011; Sun et al., 2013). It is interesting to note that despite the fact that ATF4 and p53 
have largely opposing functions in response to specific stimuli (i.e. DNA damage and 
ER-stress, PD-neurotoxins), sufficient evidence exists to indicate that each master 
regulator can influence the stability of the other (Jiang et al., 2007; Horiguchi et al., 
2013). 
4.6 Conclusion 
In summary, we suggest that ATF4 plays a pivotal role in determining neuronal survival 
in response to ER dysfunction, oxidative stress triggered by arsenite toxicity, and oxygen 
deprivation. The executive pro-death function of ATF4 is carried out through the 
expression of PUMA to modulate arsenite- and hypoxia-induced neuronal apoptosis, or 
through the intermediate CHOP, which in turn drives PUMA during ER-stress. 
Importantly, these stress paradigms are known to accumulate PUMA in a p53-
independent manner. This work provides viable therapeutic targets that could be 
considered to assist in the mitigation of chronic neuronal death observed after acute 
ischemic injury and in neurodegenerative conditions. 
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   Appendices 
Appendix A: PUMA-deficiency mitigates ER-stress-induced neuronal apoptosis 
1. 
                 
1. Cortical neurons derived from Puma wild type and knockout littermates were treated with 
3 μM TG or 4 μM TM, and the fraction of apoptotic cells was determined at 24h and 48h by 
assessing nuclear morphology following Hoechst staining. The fraction of apoptotic neurons 
was significantly decreased in Puma-/- versus Puma+/+ cultures (n≥7; *p<0.001) (Galehdar et 
al., 2010). 
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Appendix B: p53 does not regulate Puma during ER-stress 
1. 
 
2. 
                             
1. Wild type cortical neurons were treated with 10 μM camptothecin (CPT) or 4 μM 
tunicamycin (TM) for 1h, 2, 4h and 8h, and protein levels of p53 and GAPDH were then 
assessed by Western blot. 2. Cortical neurons derived from p53 wild type and p53 knockout 
littermates were treated with TG (3 μM), TM (4 μM), CPT (10 μM) or etoposide (ETP) (10 
μM). RNA was extracted 12h after treatment and Puma mRNA levels were quantified by RT-
PCR. Puma expression was normalized to S12 levels and is reported as fold increase over 
untreated controls (n≥6; *p<0.01) (Galehdar et al., 2010). 
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Appendix C: ATF4 regulates CHOP expression during ER dysfunction 
1. 
 
 1. ATF4+/+ and ATF4-/- cortical neurons were treated with 4 µM TM and after 8 and 12 hours 
CHOP and Actin protein levels were assessed by Western blot (Galehdar et al., 2010). 
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